Document:

EX-10.1

 EXECUTION VERSION 

Exhibit 10.1 
 INVESTMENT
AGREEMENT 
 dated as of October 30, 2018 

by and between 
 RENAISSANCERE
HOLDINGS LTD. 
 and 
 STATE
FARM MUTUAL AUTOMOBILE INSURANCE COMPANY 

					
	ARTICLE I PURCHASE; CLOSING	  	 	1	 
		
	 1.1      Purchase
	  	 	1	 
	 1.2      Closing
	  	 	1	 
		
	ARTICLE II REPRESENTATIONS AND WARRANTIES	  	 	3	 
		
	 2.1      
Representations and Warranties of the Company
	  	 	3	 
	 2.2      
Representations and Warranties of the Purchaser
	  	 	8	 
		
	ARTICLE III COVENANTS	  	 	10	 
		
	
3.1      Confidentiality
	  	 	10	 
	 3.2      Listing
	  	 	10	 
	 3.3      Consents
	  	 	10	 
	 3.4      Legend
	  	 	11	 
		
	ARTICLE IV INDEMNITY	  	 	11	 
		
	 4.1      
Indemnification by the Company
	  	 	11	 
	 4.2      
Indemnification by the Purchaser
	  	 	11	 
	 4.3      Indemnification
Procedure
	  	 	12	 
	 4.4      Tax Matters
	  	 	13	 
	 4.5      Survival
	  	 	13	 
	 4.6      Limitation on
Damages
	  	 	13	 
		
	ARTICLE V MISCELLANEOUS	  	 	13	 
		
	 5.1      Expenses
	  	 	13	 
	 5.2      Amendment;
Waiver
	  	 	14	 
	 5.3      
Counterparts; Electronic Transmission
	  	 	14	 
	 5.4      Governing Law
	  	 	14	 
	 5.5      WAIVER OF JURY
TRIAL
	  	 	14	 
	 5.6      Notices
	  	 	14	 
	 5.7      Entire
Agreement
	  	 	16	 
	 5.8      Assignment
	  	 	16	 
	 5.9      
Interpretation; Other Definitions
	  	 	16	 
	 5.10    Captions
	  	 	18	 
	 5.11    Severability
	  	 	18	 
	 5.12    No Third Party
Beneficiaries
	  	 	18	 
	 5.13    Public Announcements
	  	 	18	 
	 5.14    Specific Performance
	  	 	18	 
	 5.15    Termination
	  	 	18	 
	 5.16    Effects of Termination
	  	 	19	 
	 5.17    
Non-Recourse
	  	 	19	 

 Schedule A:    Form of Registration Rights Agreement 

  
 ii 

 INDEX OF DEFINED TERMS 

 

			
	Term	  	Location of Definition
	 Affiliate
	  	5.9(f)
	 Agreement
	  	Preamble
	 business day
	  	5.9(d)
	 Capitalization Date
	  	2.1(b)(1)
	 Closing
	  	1.2(a)
	 Common Shares
	  	Recitals
	 Company
	  	Preamble
	 Company Material Adverse Effect
	  	5.9(g)
	 Company Related Parties
	  	4.2
	 Company Stock Awards
	  	2.1(b)(1)
	 Company Stock Options
	  	2.1(b)(1)
	 Confidentiality Agreement
	  	3.1
	 Effect
	  	5.9(h)
	 Exchange Act
	  	2.1
	 GAAP
	  	2.1(e)(2)
	 Governmental Entity
	  	5.9(i)
	 herein/hereof/hereunder
	  	5.9(c)
	 including/includes/included/include
	  	5.9(b)
	 Indemnified Party
	  	4.3(b)
	 Indemnifying Party
	  	4.3(b)
	 Knowledge of the Company
	  	5.9(j)
	 Law
	  	5.9(k)
	 Lien
	  	5.9(l)
	 Losses
	  	4.1
	 Non-Recourse Party
	  	5.15
	 or
	  	5.9(a)
	 person
	  	5.9(e)
	 Preference Shares
	  	2.1(b)(1)
	 Purchase Price
	  	1.1
	 Purchaser
	  	Preamble
	 Purchaser Related Parties
	  	4.1
	 Registration Rights Agreement
	  	5.9(m)
	 SEC
	  	2.1(e)(1)
	 SEC Reports
	  	2.1(e)(1)
	 Securities Act
	  	2.1
	 Shares
	  	1.1
	 Subsidiaries
	  	2.1(a)(1)
	 Third Party Claim
	  	4.3(b)
	 Voting Debt
	  	2.1(b)(2)

  
 iii 

 INVESTMENT AGREEMENT, dated as of October 30, 2018 (this
“Agreement”), by and between RenaissanceRe Holdings Ltd., a company organized under the laws of Bermuda (the “Company”), and State Farm Mutual Automobile Insurance Company, an Illinois mutual insurance company (the
“Purchaser”). 
 RECITALS: 

WHEREAS, the Company proposes to issue and sell to the Purchaser (including its permitted assignees pursuant to Section 5.8) common
shares, par value $1.00 per share, of the Company (the “Common Shares”); 
 WHEREAS, on the date hereof, the Company and
the Purchaser are entering into a Registration Rights Agreement, in the form of Schedule A; 
 WHEREAS, capitalized terms used in
this Agreement have the meanings set forth in Section 5.9 or such other section indicated in the preceding Index of Defined Terms. 

NOW, THEREFORE, in consideration of the premises, and of the representations, warranties, covenants and agreements set forth herein, the
parties agree as follows: 
 ARTICLE I 

PURCHASE; CLOSING 
 
1.1    Purchase. On the terms and subject to the conditions herein, on the Closing Date, the Company agrees to sell and issue to the Purchaser, and the Purchaser agrees to purchase from the Company, 1,947,496 Common
Shares for an aggregate purchase price in cash of $250,000,000 (the “Purchase Price”) (or a purchase price per Share equal to approximately $128.37). The Common Shares to be issued and sold by the Company to the Purchaser
pursuant to this Agreement are collectively referred to as the “Shares.” 

1.2    Closing. 

(a)    Subject to the satisfaction or waiver of the conditions set forth in this Agreement, the closing of the purchase
and sale by the Purchaser of the Shares referred to in Section 1.1 pursuant to this Agreement (the “Closing”) shall be held at the offices of Willkie Farr & Gallagher LLP, 787 Seventh Avenue, New York, New York 10019,
at 10:00 a.m. New York time on the fifth Business Day following the satisfaction or waiver of the latest to occur of the conditions set forth in Section 1.3 (other than those conditions that by their nature are to be satisfied at the
Closing, but subject to their satisfaction) or at such other date, time and place as the Company and the Purchaser agree (the “Closing Date”). 

(b)    Subject to the satisfaction or waiver on or prior to the Closing Date of the applicable conditions to the Closing
in Section 1.3, at the Closing: 
 (1)    the Company will deliver to the Purchaser (i) the
Shares in book-entry form, (ii) the opinion of Conyers Dill & Pearman, Bermuda counsel to the Company, containing the opinions substantially in the form set forth in Exhibit B, (iii) the opinion of Willkie Farr

  
 1 

 
& Gallagher LLP, U.S. counsel to the Company, containing the opinions substantially in the form set forth in Exhibit C and (iv) all other documents, instruments and writings
required to be delivered by the Company to the Purchaser pursuant to this Agreement or otherwise required in connection herewith. 

(2)    the Purchaser will deliver or cause to be delivered (i) to a bank account previously
designated by the Company, the Purchase Price by wire transfer of immediately available funds and (ii) all other documents, instruments and writings required to be delivered by the Purchaser to the Company pursuant to this Agreement or
otherwise required in connection herewith. 
 (c)    Closing Conditions. 

(1)    The obligation of the Purchaser, on the one hand, and the Company, on the other hand, to effect the
Closing is subject to the satisfaction or written waiver by the Purchaser and the Company prior to the Closing of the following conditions: 

(a)    the waiting period (and any extension thereof) applicable to the consummation of the transactions
contemplated hereby under the HSR Act shall have expired or been terminated or Purchaser shall have received such other evidence satisfactory to Purchaser in its sole discretion that the transactions contemplated hereby by qualify for an exemption
under the HSR Act; and 
 (b)    no temporary restraining order, preliminary or permanent injunction or
other judgment or order issued by any Governmental Entity, and no Law shall be in effect restraining, enjoining, making illegal or otherwise prohibiting the consummation of the transactions contemplated by this Agreement. 

(2)    The obligation of the Purchaser to effect the Closing is subject to the satisfaction or written
waiver by the Purchaser prior to the Closing of the following conditions: 
 (a)    the representations
and warranties of the Company set forth in Section 2.1 (disregarding all qualifications as to materiality or Company Material Adverse Effect set forth therein) shall be true and correct as of the Closing Date as though made on the Closing Date
(except to the extent any such representation or warranty speaks as of the date of this Agreement or any other specific date, in which case such representation or warranty shall be true and correct as of such date), except where the failure of such
representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect; 

(b)    the Company shall have performed or complied with in all material respects all covenants and
agreements required to be performed or complied with by the Company under this Agreement on or prior to the Closing Date; 

  
 2 

 (c)    since the date of this Agreement, there shall not
have occurred any Company Material Adverse Effect; and 
 (d)    Purchaser shall have received from the
Company each delivery required pursuant to Section 1.2(b)(1). 
 (3)    The obligation of the
Company to effect the Closing is subject to the satisfaction or written waiver by the Company to the Closing of the following conditions: 

(a)    the representations and warranties of Purchaser set forth in Section 2.2 (disregarding all
qualifications as to materiality set forth therein) shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent any such representation or warranty speaks as of the date of this Agreement or any other
specific date, in which case such representation or warranty shall be true and correct as of such date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate,
reasonably be expected to materially impair or delay the Purchaser’s ability to perform or comply with its obligations under this Agreement and the Registration Rights Agreement or to consummate the transactions contemplated hereby or thereby;
and 
 (b)    the Purchaser shall have performed or complied with in all material respects all covenants
and agreements required to be performed or complied with by the Purchaser under this Agreement on or prior to the Closing Date. 
 
ARTICLE II 
 REPRESENTATIONS AND WARRANTIES 

2.1    Representations and Warranties of the Company. Except as set forth
(x) in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, the Company’s Quarterly Reports on Form 10-Q for the quarters
ended March 31, 2018 and June 30, 2018 and the Company’s Definitive Proxy Statement dated March 29, 2018, excluding any disclosures set forth in risk factors or any “forward looking statements” within the meaning of the
Securities Act of 1933 (the “Securities Act”) or the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or (y) in a correspondingly identified schedule attached hereto (provided that any such
disclosure shall be deemed to be disclosed with respect to each other representation and warranty to which the relevance of such exception is reasonably apparent on the face of such disclosure), the Company represents and warrants to the Purchaser,
as of the date hereof and as of the Closing Date (except to the extent made only as of a specified date in which case as of such date), that: 

(a)    Incorporation and Authority. 

(1)    Each of the Company and Renaissance Reinsurance Ltd., Renaissance Reinsurance U.S. Inc. and
RenaissanceRe Finance Inc. (collectively, the “Subsidiaries”) has been duly incorporated and is validly existing as a corporation in good standing under the 

  
 3 

 
laws of the jurisdiction in which it is chartered or organized with full corporate power and authority to own or lease, as the case may be, and to operate its properties and conduct its business
as presently conducted. True and complete copies of the Company’s Memorandum of Association and Bye-Laws, as amended through the date hereof, are included in the SEC Reports. 

(2)    The Company has all requisite corporate or other applicable organizational power to enter into,
consummate the transactions contemplated by, and carry out its obligations under this Agreement and the Registration Rights Agreement. The execution, delivery and performance by the Company of this Agreement and the Registration Rights Agreement and
the consummation by the Company of the transactions contemplated by this Agreement (including the issuance of the Shares) and the Registration Rights Agreement have been duly authorized by all requisite corporate or other similar organizational
action on the part of the Company. This Agreement and the Registration Rights Agreement have been duly executed and delivered by the Company. Assuming due authorization, execution and delivery by the other parties hereto, each of this Agreement and
the Registration Rights Agreement constitutes, the legal, valid and binding obligation of the Company, enforceable against it in accordance with its terms, subject in each case to the effect of any applicable bankruptcy, reorganization, insolvency,
moratorium or similar Laws now or hereafter in effect relating to or affecting creditors’ rights and remedies generally and subject, as to enforceability, to the effect of general equitable principles (regardless of whether enforcement is
sought in a proceeding in equity or at law). 
 (3)    Neither the execution and delivery by the Company
of this Agreement or the Registration Rights Agreement, nor the consummation of the transactions contemplated hereby (including the issuance of the Shares) or thereby, nor compliance by the Company with any of the provisions hereof or thereof will
(a) violate or conflict with the organizational documents of the Company or any Subsidiary, (b) conflict with or violate any Law applicable to the Company or any of its subsidiaries or by which any of their respective properties or assets
is bound or subject or (c) result in any breach of, or constitute a default (or event which, with the giving of notice or lapse of time or both, would constitute a default) under, or give to any person any rights of termination, acceleration or
cancellation of or result in the creation of any Lien on any of the assets or properties of the Company, any material indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other contract, agreement, obligation,
condition, covenant or instrument to which the Company or any of its Subsidiaries is a party or by which any of them or any of their respective properties or assets is bound or subject, except, in the case of clauses (b) and (c), for any such
conflicts, violations, breaches, defaults, terminations, accelerations, cancellations or creations as, individually or in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect or materially impair or delay the
Company’s ability to perform or comply with its obligations under this Agreement and the Registration Rights Agreement or to consummate the transactions contemplated hereby or thereby. 

(4)    Other than under the securities or blue sky laws of the applicable states, no notice to,
registration, declaration or filing with, exemption or review by, or authorization, order, consent or approval of, any Governmental Entity, nor expiration or termination of any statutory waiting period, is necessary for the execution, delivery and
performance by the Company of this Agreement or the Registration Rights Agreement or the consummation by the Company of the transactions contemplated hereby or thereby. 

  
 4 

 (b)    Capitalization. 

(1)    The authorized capital stock of the Company consists of 225,000,000 Common Shares and 100,000,000
Preference Shares, par value $1.00 per share (the “Preference Shares”). As of the close of business on October 29, 2018 (the “Capitalization Date”), there were 40,265,961 Common Shares outstanding and
16,010,000 Preference Shares outstanding. As of the close of business on the Capitalization Date, (i) no Common Shares were reserved for issuance upon the exercise or payment of stock options outstanding on such date (“Company Stock
Options”) and no Common Shares were reserved for issuance upon the exercise or payment of stock units (including restricted stock and restricted stock units or other equity-based incentive awards granted pursuant to any plans, agreements or
arrangements of the Company and outstanding on such date), including Company Stock Options (collectively, the “Company Stock Awards”) and (ii) no Common Shares were held by the Company in its treasury. All of the issued and
outstanding Common Shares have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights. All of the outstanding shares of capital stock of each Subsidiary have been duly and validly authorized and
issued and are fully paid and non-assessable. From the Capitalization Date through and as of the date of this Agreement, no other Common Shares or Preference Shares have been issued other than Common Shares
issued in respect of the exercise of Company Stock Options or grant or payment of Company Stock Awards in the ordinary course of business. The Company does not have outstanding stockholder purchase rights or “poison pill” or any similar
arrangement in effect. 
 (2)    No bonds, debentures, notes or other indebtedness having the right to
vote (or convertible into or exchangeable for, securities having the right to vote) on any matters on which the stockholders of the Company may vote (“Voting Debt”) are issued and outstanding. Except (i) pursuant to any
cashless exercise provisions of any Company Stock Options or pursuant to the surrender of shares to the Company or the withholding of shares by the Company to cover tax withholding obligations under Company Stock Options or Company Stock Awards,
(ii) as set forth in Section 2.1(b)(1), and (iii) pursuant to the Stock Purchase Agreement, dated as of October 30, 2018, by and between the Company and Tokio Marine & Nichido Fire Insurance Co., Ltd., the Company does
not have and is not bound by any outstanding options, preemptive rights, rights of first offer, warrants, calls, commitments or other rights or agreements calling for the purchase or issuance of, or securities or rights convertible into, or
exchangeable for, any Common Shares or any other equity securities of the Company or Voting Debt or any securities representing the right to purchase or otherwise receive any shares of capital stock of the Company (including any rights plan or
agreement). 
 (c)    Sale of Securities. Based in part on the Purchaser’s representations in
Section 2.2, the offer and sale of the Shares is exempt from the registration and prospectus delivery requirements of the Securities Act and the rules and regulations promulgated thereunder. Without limiting the foregoing, neither the Company
nor, to the Knowledge of the Company, any other 

  
 5 

 
person authorized by the Company to act on its behalf, has engaged in a general solicitation or general advertising (within the meaning of Regulation D of the Securities Act) of investors with
respect to offer or sales of the Shares and neither the Company nor, to the Knowledge of the Company, any person acting on its behalf, has made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause the offering or issuance of the Shares under this Agreement to be integrated with prior offerings by the Company for purposes of the Securities Act that would result in Regulation D or any other applicable exemption from registration
under the Securities Act not being available, nor will the Company take any action or steps that would cause the offering or issuance of the Shares under this Agreement to be integrated with other offerings. 

(d)    Company Shares. The Shares to be delivered to the Purchaser hereunder have been duly authorized and, when
delivered to and paid for by the Purchaser pursuant to this Agreement, shall be validly issued, fully paid and non-assessable and the issuance of the Shares will not be subject to any pre-emptive rights. As of the Closing, the Company shall have the right, authority and power to sell, assign and transfer the Shares to the Purchaser. Upon delivery of such Shares to the Purchaser, the Purchaser
shall acquire good, valid and marketable title to the Shares, free and clear of all Liens other than restrictions on transfer imposed by applicable securities Laws. 

(e)    SEC Reports; Financial Statements. 

(1)    The Company has filed with or furnished to the Securities and Exchange Commission (the
“SEC”) all forms, reports and documents (together with all amendments thereof and supplements thereto) required to be filed by it pursuant to the Securities Act or Exchange Act since January 1, 2017 (together with all exhibits
and schedules thereto and all information incorporated therein by reference, the “SEC Reports”) on a timely basis. The SEC Reports (as of the date filed with the SEC and, in the case of registration statements, prospectuses and
proxy statements, on the dates of effectiveness and the dates of mailing, respectively, and, in the case of any SEC Reports amended or superseded by a filing prior to the date hereof, then on the date of such amending or superseding filing) (i)
complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act, as the case may be, and the applicable rules and regulations promulgated by the SEC thereunder and (ii) did not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 

(2)    The consolidated financial statements of the Company included or incorporated by reference in the
SEC Reports, as of the date filed with the SEC (and, in the case of registration statements, prospectuses and proxy statements, on the dates of effectiveness and the dates of mailing, respectively, and, in the case of any SEC Report amended or
superseded by a filing prior to the date hereof, then on the date of such amending or superseding filing), complied in all material respects with applicable accounting requirements and with the published rules and regulations of the SEC with respect
thereto, were prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) applied on a consistent basis during the periods indicated (except as may be indicated in the notes thereto or, in the
case of unaudited statements, as permitted by 

  
 6 

 
Form 10-Q of the SEC), and fairly presented, in all material respects (subject, in the case of the unaudited statements, to normal, recurring audit
adjustments not material in amount), the consolidated financial position of the Company and its consolidated Subsidiaries as of the date of such financial statements and the consolidated results of their operations and cash flows for each of the
periods then ended. 
 (3)    The internal control over financial reporting (as such term is defined in
Rule 13a-15(f) under the Exchange Act) of the Company were effective at December 31, 2017, and since December 31, 2017 there have been no changes in internal controls over financial reporting that
have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting. With respect to preparation of consolidated financial statements of the Company, the Company is not aware of any
material weakness in its internal control over financial reporting. 
 (f)    Brokers and Finders. No broker,
finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the consummation of the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company or
its Affiliates. 
 (g)    Litigation. There are no actions pending or, to the Knowledge of the Company,
threatened in writing against the Company or any of its Affiliates or any of their respective assets, properties or businesses that (i) challenges the transactions contemplated by this Agreement or (ii) individually or in the aggregate
would reasonably be expected to have a Company Material Adverse Effect. 
 (h)    Compliance with Laws. Neither
the Company nor any of its Subsidiaries is, or since January 1, 2017 has been, in violation of any applicable Law, except where such violation would not, individually or in the aggregate, reasonably be expected to have, or has not had, a
Company Material Adverse Effect. To the Knowledge of the Company as of the date of this Agreement, neither the Company nor any of its Subsidiaries is being investigated with respect to any applicable Law, except for such of the foregoing as would
not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. 

(i)    Absence of Changes. Since December 31, 2017, there has not been any Company Material Adverse Effect.

 (j)    Listing and Maintenance Requirements. The Common Shares are registered pursuant to Section 12(b)
of the Exchange Act, and the Company has taken no action designed to, or which to the Knowledge of the Company is reasonably likely to, have the effect of, terminating the registration of the Common Shares under the Exchange Act nor has the Company
received as of the date of this Agreement any notification that the SEC is contemplating terminating such registration. 

(k)    No Additional Representations. Except for the representations and warranties made by the Company in this
Section 2.1, none of the Company or any of its Affiliates or representatives makes any other representation or warranty of any kind or nature whatsoever, oral or written, express or implied, with respect to itself, its Affiliates, their
respective businesses, this Agreement or the transactions contemplated by the Agreement. 

  
 7 

 (l)    No Other Purchaser Representations or
Warranties. Except for the representations and warranties expressly set forth in Section 2.2 and in any certificate or other document delivered in connection with this Agreement or the Registration Rights Agreement, the Company
hereby acknowledges that neither the Purchaser nor any of its Affiliates, nor any other person, has made or is making any other express or implied representation or warranty with respect to the Purchaser. 

2.2    Representations and Warranties of the Purchaser. The Purchaser hereby
represent and warrant to the Company, as of the date hereof and as of the date hereof (except to the extent made only as of a specified date in which case as of such date), that: 

(a)    Incorporation and Authority. 

(1)    The Purchaser is duly organized, validly existing and in good standing under the Laws of its
jurisdiction of organization. The Purchaser has all requisite corporate or other applicable organizational power to enter into, consummate the transactions contemplated by, and carry out its obligations under this Agreement and the Registration
Rights Agreement. 
 (2)    The execution and delivery by the Purchaser of this Agreement and the
Registration Rights Agreement and the consummation by the Purchaser of the transactions contemplated by this Agreement and the Registration Rights Agreement have been prior to the Closing duly authorized by all requisite corporate or other similar
organizational action on the part of the Company. This Agreement and Registration Rights Agreement have been duly executed and delivered by the Purchaser. Assuming due authorization, execution and delivery by the other parties hereto, each of this
Agreement and the Registration Rights Agreement constitutes the legal, valid and binding obligation of the Purchaser, enforceable against it in accordance with its terms, subject in each case to the effect of any applicable bankruptcy,
reorganization, insolvency, moratorium or similar Laws now or hereafter in effect relating to or affecting creditors’ rights and remedies generally and subject, as to enforceability, to the effect of general equitable principles (regardless of
whether enforcement is sought in a proceeding in equity or at law). 
 (3)    Neither the execution and
delivery by the Purchaser of this Agreement or the Registration Rights Agreement, nor the consummation of the transactions contemplated hereby or thereby, nor compliance by the Purchaser with any of the provisions hereof or thereof will
(a) violate or conflict with the organizational documents of the Purchaser, (b) conflict with or violate any Law applicable to the Company or by which any of its properties or assets is bound or subject or (c) result in any breach of,
or constitute a default (or event which, with the giving of notice or lapse of time or both, would constitute a default) under, or give to any person any rights of termination, acceleration or cancellation of or result in the creation of any Lien on
any of the assets or properties of the Purchaser, any material contract to which the Purchaser is a party or by which any of its respective properties or assets is bound or subject, except, in the case of clauses (b) and (c), for any such
conflicts, violations, breaches, defaults, terminations, accelerations, cancellations or creations as, individually or in the aggregate, would not reasonably be expected to materially impair or delay the Purchaser’s ability to perform or comply
with its obligations under this Agreement and the Registration Rights Agreement or to consummate the transactions contemplated hereby or thereby. 

  
 8 

 (4)    Other than under the securities or blue sky laws
of the applicable states, no notice to, registration, declaration or filing with, exemption or review by, or authorization, order, consent or approval of, any Governmental Entity, nor expiration or termination of any statutory waiting period, is
necessary for the execution, delivery and performance by the Company of this Agreement or the Registration Rights Agreement or the consummation by the Purchaser of the transactions contemplated by this Agreement or the Registration Rights Agreement.

 (b)    Purchase for Investment. The Purchaser acknowledges that the Shares have not been registered under the
Securities Act or under any state securities laws. The Purchaser (1) acknowledges that it is acquiring the Shares pursuant to an exemption from registration under the Securities Act solely for investment with no present intention to distribute
any of the Shares to any person in violation of applicable securities laws, (2) will not sell or otherwise dispose of any of the Shares, except in compliance with the registration requirements or exemption provisions of the Securities Act, any
other applicable securities laws, (3) has such knowledge and experience in financial and business matters and in investments of this type that it is capable of evaluating the merits and risks of its investment in the Shares and of making an
informed investment decision, (4) is an “accredited investor” (as that term is defined by Rule 501 of the Securities Act), (5) is a “qualified institutional buyer” (as that term is defined in Rule 144A of the Securities
Act), and (6) (A) has been furnished with or has had full access to all the information that it considers necessary or appropriate to make an informed investment decision with respect to the Shares, (B) has had an opportunity to discuss with
management of the Company the intended business and financial affairs of the Company and to obtain information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any
information furnished to it or to which it had access and (C) can bear the economic risk of (x) an investment in the Shares indefinitely and (y) a total loss in respect of such investment. The Purchaser has such knowledge and
experience in business and financial matters so as to enable it to understand and evaluate the risks of and form an investment decision with respect to, its investment in the Shares and to protect its own interest in connection with such investment.

 (c)    Financial Capability. The Purchaser at the Closing will have available funds necessary to consummate
the Closing on the terms and conditions contemplated by this Agreement. The Purchaser is not aware of any reason why the funds sufficient to fulfill its obligations under Article I will not be available on the date hereof. 

(d)    Brokers and Finders. Neither the Purchaser nor its Affiliates or any of their respective officers,
directors, employees or agents has employed any broker or finder for which the Company will incur any liability for any financial advisory fees, brokerage fees, commissions or finder’s fees. 

(e)    No Additional Representations. Except for the representations and warranties made by the Purchaser in this
Section 2.2, none of the Purchaser or any of its Affiliates or representatives makes any other representation or warranty of any kind or nature whatsoever, oral or written, express or implied, with respect to itself, its Affiliates, their
respective businesses, this Agreement or the transactions contemplated by the Agreement. 

  
 9 

 (f)    No Other Company Representations or
Warranties. Except for the representations and warranties expressly set forth in Section 2.1 and in any certificate or other document delivered in connection with this Agreement or the Registration Rights Agreement, the Purchaser
hereby acknowledges that neither the Company nor any of its Affiliates, nor any other person, has made or is making any other express or implied representation or warranty with respect to the Company. 

ARTICLE III 

COVENANTS 
 
3.1    Confidentiality. The Confidentiality Agreement, dated as of October 19, 2018 (the “Confidentiality Agreement”), by and between the Company and the Purchaser shall remain in full force and
effect. 
 3.2    Listing. The Company shall promptly apply and use its
reasonable efforts to cause the Shares to be approved for listing on the New York Stock Exchange, subject to official notice of issuance, following the Closing Date. 

3.3    Efforts. Subject to the other terms and conditions of this Agreement, each
of the parties hereto shall use its respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under this Agreement and applicable Law to, as promptly as
reasonably practicable following the date of this Agreement, consummate the Closing. In furtherance of the foregoing, each of the parties agrees to make, as promptly as reasonably practicable following the date of this Agreement and in any event
within 20 Business Days of the date hereof, the appropriate filings and notifications required by the HSR Act and to supply as promptly as practicable any additional information and documentary material that may be reasonably requested under such
requirements. Notwithstanding the foregoing or anything else in this Agreement to the contrary, the Purchaser and its Affiliates shall not be required to (i) propose, offer, commit, agree, or consent to (A) sell, divest, lease, license,
transfer, hold separate, or otherwise dispose of any assets, businesses, products or product lines, (B) terminate, amend, or modify any existing relationships, ventures, contractual rights or liabilities, or (C) take or agree to take any
action that after the Closing would limit the freedom of the Purchaser or any of its Affiliates with respect to, or its ability to retain, one or more of its or its Affiliates’ businesses, product lines, or assets, (ii) contest, defend, or
resist any lawsuit or proceeding brought or threatened to be brought challenging or seeking to enjoin, restrain, prohibit, or otherwise make illegal any of the transactions contemplated by this Agreement, or (iii) appeal or seek to have
vacated, lifted, reversed, or overturned any order, whether temporary, preliminary, or permanent, that enjoins, restrains, prohibits, or otherwise makes illegal any of the transactions contemplated by this Agreement. 

  
 10 

 3.4    Legend. The Purchaser
agrees that all certificates or other instruments (including book-entry notations) representing the Shares subject to this Agreement will bear a legend substantially to the following effect: 

THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY
STATE, AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AND UNDER THE SECURITIES LAWS OF ANY APPLICABLE STATE OR AN OPINION OF COUNSEL SATISFACTORY TO
THE CORPORATION TO THE EFFECT THAT SUCH REGISTRATIONS ARE NOT REQUIRED. THE PURCHASER ACKNOWLEDGES THAT THE SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR UNDER ANY STATE SECURITIES LAWS AND AGREES THAT IT WILL NOT SELL OR OTHERWISE
DISPOSE OF ANY OF THE SHARES, EXCEPT IN COMPLIANCE WITH THE REGISTRATION REQUIREMENTS OR EXEMPTION PROVISIONS OF THE SECURITIES ACT, ANY OTHER APPLICABLE SECURITIES LAWS. 

ARTICLE IV 

INDEMNITY 
 
4.1    Indemnification by the Company. From and after the Closing, the Company agrees to indemnify the Purchaser and its Affiliates and its officers, directors, managers, employees and agents (collectively,
“Purchaser Related Parties”) from, and hold each of them harmless against, any and all losses, damages, actions, suits, proceedings (including any investigations, litigation or inquiries), demands and causes of action
(“Losses”), and, in connection therewith, and promptly upon demand, pay or reimburse each of them for all reasonable and documented out-of-pocket costs,
losses, liabilities, damages or expenses of any kind or nature whatsoever (including the reasonable fees and disbursements of counsel and all other reasonable and documented
out-of-pocket expenses incurred in connection with investigating, defending or preparing to defend any such matter that may be incurred by them or asserted against or
involve any of them), whether or not involving a Third Party Claim, incurred by or asserted against such Purchaser Related Parties, as a result of or arising out of (i) the failure of the representations or warranties made by the Company
contained in Section 2.1 or in any certificate delivered pursuant hereto to be true and correct, (ii) the breach of any of the covenants of the Company contained herein or (iii) the transactions contemplated hereby; provided that in
the case of the immediately preceding clause (i), such claim for indemnification relating to a breach of any representation or warranty is made prior to the expiration of such representation or warranty as set forth in Section 4.5; provided,
further that for purposes of determining when an indemnification claim has been made, the date upon which a Purchaser Related Party shall have given written notice (stating in reasonable detail the basis of the claim for indemnification) to the
Company shall constitute the date upon which such claim has been made; provided, further, that clause (iii) shall only relate to Third Party Claims. 

4.2    Indemnification by the Purchaser. From and after the Closing, the Purchaser
agrees to indemnify the Company and its officers, directors, managers, employees, and agents (collectively, “Company Related Parties”) from, and hold each of them harmless against, any and all Losses, and, in connection therewith,
and promptly upon demand, pay or reimburse each of them for all reasonable and documented out-of-pocket costs, losses, liabilities, damages or

  
 11 

 
expenses of any kind or nature whatsoever (including the reasonable fees and disbursements of counsel and all other reasonable and documented out-of-pocket expenses incurred in connection with investigating, defending or preparing to defend any such matter that may be incurred by them or asserted against or involve any of them), whether or not
involving a Third Party Claim, incurred by or asserted against such Company Related Parties as a result of or arising out of (i) the failure of any of the representations or warranties made by the Purchaser contained in Section 2.2 to be
true and correct or (ii) the breach of any of the covenants of the Purchaser contained herein; provided that in the case of the immediately preceding clause (i), such claim for indemnification relating to a breach of any representation or
warranty is made prior to the expiration of such representation or warranty as set forth in Section 4.5; provided, further that for purposes of determining when an indemnification claim has been made, the date upon which a Company Related Party
shall have given written notice (stating in reasonable detail the basis of the claim for indemnification) to the Purchaser shall constitute the date upon which such claim has been made. 

4.3    Indemnification Procedure. 

(a)    A claim for indemnification for any matter not involving a Third Party Claim may be asserted by written notice to
the party from whom indemnification is sought; provided, however, that failure to so notify the indemnifying party shall not preclude the indemnified party from any indemnification that it may claim in accordance with this Article IV unless and to
the extent the Indemnifying Party is materially prejudiced by such failure, except as otherwise provided in Sections 4.1 and 4.2. 

(b)    Promptly after any Company Related Party or Purchaser Related Party (hereinafter, the “Indemnified
Party”) has received notice of any indemnifiable claim hereunder, or the commencement of any action, suit or proceeding by a third person, which the Indemnified Party believes in good faith is an indemnifiable claim under this Agreement
(each, a “Third Party Claim”), the Indemnified Party shall give the indemnitor hereunder (the “Indemnifying Party”) written notice of such Third Party Claim but failure or delay to so notify the Indemnifying Party
will not relieve the Indemnifying Party from any liability it may have to such Indemnified Party hereunder except to the extent that the Indemnifying Party is materially prejudiced by such failure or delay. Such notice shall state the nature and the
basis of such Third Party Claim to the extent then known. The Indemnifying Party shall have the right to assume and control the defense of, and settle, at its own expense and by its own counsel, any such matter as long as the Indemnifying Party
pursues the same diligently and in good faith. If the Indemnifying Party undertakes to assume and control the defense or settle such Third Party Claim, it shall promptly, and in no event later than ten (10) business days after notice of such
claim, notify the Indemnified Party of its intention to do so, and the Indemnified Party shall cooperate with the Indemnifying Party and its counsel in all reasonable respects in the defense thereof and/or the settlement thereof. Such cooperation
shall include, but shall not be limited to, furnishing the Indemnifying Party with any books, records and other information reasonably requested by the Indemnifying Party and in the Indemnified Party’s possession or control. Such cooperation of
the Indemnified Party shall be at the cost of the Indemnifying Party. After the Indemnifying Party has notified the Indemnified Party of its intention to undertake to defend or settle any such asserted liability, and for so long as the Indemnifying
Party diligently pursues such defense, the Indemnifying Party shall not be liable for any additional legal expenses incurred by the Indemnified Party in connection with any defense or settlement of such asserted liability; provided, however, that
the Indemnified Party shall be 

  
 12 

 
entitled (i) at its own expense, to participate in the defense of such asserted liability and any negotiations of the settlement thereof and (ii) if (A) the Indemnifying Party has,
within fifteen (15) business days of when the Indemnified Party provides written notice of a Third Party Claim, failed to (y) assume the defense or settlement of such Third Party Claim and (z) notify the Indemnified Party of such
assumption, or (B) the defendants in any such action include both the Indemnified Party and the Indemnifying Party and counsel to the Indemnified Party shall have concluded that there may be reasonable defenses available to the Indemnified
Party that are different from or in addition to those available to the Indemnifying Party or if the interests of the Indemnified Party reasonably may be deemed to conflict with the interests of the Indemnifying Party, then, in each case, the
Indemnified Party shall have the right to select one (1) separate counsel and, upon prompt notice to the Indemnifying Party, to assume such settlement or legal defense and otherwise to participate in the defense of such action, with the
expenses and fees of such separate counsel and other expenses related to such participation to be reimbursed by the Indemnifying Party as incurred. Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not settle any
indemnified claim without the consent of the Indemnified Party, unless the settlement thereof imposes no liability or obligation on, and includes a complete release from liability of, and does not contain any admission of wrongdoing by, the
Indemnified Party. 
 4.4    Tax Matters. All indemnification payments under
this Article IV shall be treated as adjustments to the Purchase Price for tax purposes, except as otherwise required by applicable Law. 
 
4.5    Survival. The representations and warranties of the parties contained in this Agreement shall survive for twelve (12) months following the Closing. All of the covenants or other agreements of the parties
contained in this Agreement shall survive until fully performed or fulfilled, unless and to the extent that non-compliance with such covenants or agreements is waived in writing by the party entitled to such
performance. 
 4.6    Limitation on Damages. Notwithstanding any other
provision of this Agreement, except in the case of fraud, no party hereto shall have any liability to the other party in excess of the Purchase Price, and neither party shall be liable for any exemplary or punitive damages or any other damages to
the extent not reasonably foreseeable arising out of or in connection with this Agreement or the transactions contemplated hereby (in each case, unless any such damages are awarded pursuant to a Third Party Claim). 

ARTICLE V 

MISCELLANEOUS 
 
5.1    Expenses. Each of the parties will bear and pay all costs and expenses incurred by it or on its behalf in connection with the transactions contemplated pursuant to this Agreement; provided that the Company
shall, upon the Closing of the transaction contemplated hereby, or thereafter, reimburse the Purchaser for its reasonable and documented out-of-pocket third-party costs
and expenses incurred in connection with due diligence, the negotiation and preparation of this Agreement and the Registration Rights Agreement and undertaking of the transactions contemplated pursuant to this Agreement and the Registration Rights
Agreement, including any such costs and expenses incurred after the Closing (including fees and expenses of attorneys and 

  
 13 

 
accounting and financial advisers in connection with the transactions contemplated pursuant to this Agreement); provided that the maximum amount of such reimbursable costs and expenses shall not
exceed $100,000 in the aggregate. In addition, the Company and the Purchaser shall each be responsible for fifty percent (50%) of any fees and expenses (including filing fees and fees and expenses of counsel) incurred in connection with making the
filings and notifications required by the HSR Act, provided that, once the Company has borne $70,000 of such fees, the Purchaser shall be responsible for one hundred percent (100%) of any such fees in excess of such amount. 

5.2    Amendment; Waiver. No amendment or waiver of any provision of this
Agreement will be effective with respect to any party unless made in writing and signed by an officer or a duly authorized representative of such party. No failure or delay by any party in exercising any right, power or privilege hereunder shall
operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. No waiver of any party to this Agreement will be effective unless it
is in a writing signed by a duly authorized officer of the waiving party that makes express reference to the provision or provisions subject to such waiver. The rights and remedies herein provided shall be cumulative and not exclusive of any rights
or remedies provided by law. 
 5.3    Counterparts; Electronic Transmission.
For the convenience of the parties hereto, this Agreement may be executed in any number of separate counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts will together constitute the same agreement.
Executed signature pages to this Agreement may be delivered by facsimile or other means of electronic transmission and such facsimiles or other means of electronic transmission will be deemed as sufficient as if actual signature pages had been
delivered. 
 5.4    Governing Law. This Agreement will be governed by and
construed in accordance with the laws of the State of New York. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts located in the Borough of Manhattan for any actions,
suits or proceedings arising out of or relating to this Agreement and the transactions contemplated hereby. The parties hereby irrevocably and unconditionally consent to the jurisdiction of such courts (and of the appropriate appellate courts
therefrom) in any such action, suit or proceeding and irrevocably waive, to the fullest extent permitted by law, any objection that they may now or hereafter have to the laying of the venue of any such action, suit or proceeding in any such court or
that any such action, suit or proceeding which is brought in any such court has been brought in an inconvenient forum. Process in any such action, suit or proceeding may be served on any party anywhere in the world, whether within or without the
jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on such party as provided in Section 5.6 shall be deemed effective service of process on such party. 

5.5    WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY
WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

5.6    Notices. Any notice, request, instruction or other document to be given
hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the 

  
 14 

 
date of delivery if delivered personally or by telecopy or facsimile, upon confirmation of receipt, (b) on the first business day following the date of dispatch if delivered by a recognized next-day courier service, or (c) on the third business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be
delivered as set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice. 

If to Purchaser: 
 State Farm
Mutual Automobile Insurance Company 
 Three State Farm Plaza South, K-3 

Bloomington, IL 61710 
 Attention:
Michael Remmes 
 E-mail: michael.remmes.c5xt@statefarm.com 

Facsimile: 309-994-0035 

with copies to: 
 State Farm
Mutual Automobile Insurance Company 
 One State Farm Plaza, A-3 

Bloomington, IL 61710 
 Attention:
Mark Cavanaugh 
 E-mail: mark.cavanaugh.lnms@statefarm.com 

Facsimile: 309-766-5594 

Mayer Brown LLP 
 71 South Wacker
Drive 
 Chicago, Illinois 60606 

Attention: Edward S. Best 
 E-mail: ebest@mayerbrown.com 
 Facsimile:
312-706-8106 
 If to the Company: 

RenaissanceRe Holdings Ltd. 
 12
Crow Lane 
 Pembroke HM19, Bermuda 

Attention: General Counsel 
 E-mail: shw@renre.com 
 Facsimile:
441-292-9453 

  
 15 

 with a copy to: 

Willkie Farr & Gallagher LLP 

787 Seventh Avenue 
 New York, NY
10019 

	 	Attention:	 Steven J. Gartner 

	 	    	 Sean M. Ewen 

	 	E-mail:	 sgartner@willkie.com 

	 	    	 sewen@willkie.com 

	 	Facsimile:	 212-728-9867

 5.7    Entire Agreement. This Agreement (including the
Schedules hereto and the documents and instruments referred to in this Agreement), together with the Confidentiality Agreement, constitutes the entire agreement among the parties and supersedes all other prior agreements and understandings, both
written and oral, between the parties with respect to the subject matter hereof and transactions contemplated hereby. 
 
5.8    Assignment. Neither this Agreement, nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto (whether by operation of Law or otherwise) without the prior written
consent of the other party; provided that the Purchaser may assign to one or more of its wholly owned subsidiaries all or a portion of its rights under this Agreement. 

5.9    Interpretation; Other Definitions. Wherever required by the context of this
Agreement, the singular shall include the plural and vice versa, and the masculine gender shall include the feminine and neuter genders and vice versa, and references to any agreement, document or instrument shall be deemed to refer to such
agreement, document or instrument as amended, supplemented or modified from time to time. All article, section, paragraph or clause references not attributed to a particular document shall be references to such parts of this Agreement, and all
exhibit, annex, letter and schedule references not attributed to a particular document shall be references to such exhibits, annexes, letters and schedules to this Agreement. In addition, the following terms are ascribed the following meanings: 

(a)    the word “or” is not exclusive; 

(b)    the words “including,” “includes,” “included” and
“include” are deemed to be followed by the words “without limitation”; 
 (c)    the terms
“herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular section, paragraph or subdivision; 

(d)    the term “business day” means any day except Saturday, Sunday and any day which shall be a legal
holiday or a day on which banking institutions in the State of New York generally are authorized or required by law or other governmental action to close; and 

(e)    the term “person” has the meaning given to it in Section 3(a)(9) of the Exchange Act and as
used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act. 
 (f)    “Affiliate” means, with respect
to any specified person, any other person that, at the time of determination, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such specified person. 

  
 16 

 (g)    “Company Material Adverse Effect” means any
change, effect, event, occurrence, condition, state of facts or development that, either alone or in combination, has had, or would be reasonably expected to have, (a) a materially adverse effect on the business, operations, assets, liabilities
or condition (financial or otherwise) or results of operations of the Company, taken as a whole; provided, however, that none of the following shall constitute or be deemed to contribute to a Company Material Adverse Effect, or shall
otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would be reasonably likely to occur: any adverse effect arising out of, resulting from or attributable to (i) the global economy generally
or capital or financial markets generally, including changes in interest or exchange rates, (ii) political conditions generally, (iii) conditions generally affecting the insurance industry in which the business of the Company and its
subsidiaries participates, (iv) any hostilities, act of war, sabotage, terrorism or military actions, or any escalation or worsening of any such hostilities, act of war, sabotage, terrorism or military actions, (v) any changes in
applicable Law, U.S. generally accepted accounting principles or the enforcement or interpretation thereof, (vi) actions required to be taken or omitted pursuant to this Agreement, (vii) the failure of the Company to meet or achieve the
results set forth in any internal budget, plan, projection or forecast; provided that this clause (vii) will not prevent a determination that any change, effect or other cause underlying such failure to meet budgets, plans, projections
or forecasts has resulted in or contributed to a Company Material Adverse Effect; provided that the matters described in clauses (i) - (iv) shall be included and taken into account in the term “Company Material Adverse
Effect” to the extent any such matter has a disproportionate adverse impact on the business, operations, assets, liabilities or condition (financial or otherwise) or results of operations of the Company and its subsidiaries, taken as a whole,
relative to the other participants in the industries in which they operate; and (b) a material impairment on or material delay in the ability of the Company to perform its material obligations under this Agreement or the Registration Rights
Agreement or to consummate the transactions contemplated by this Agreement. 
 (h)    “Effect” means
any change, event, effect, development or circumstance. 
 (i)    “Governmental Entity” means any
court, administrative or regulatory agency or commission or other governmental or arbitral body or authority or instrumentality, including any state-controlled or owned corporation or enterprise, in each case whether federal, state, local or
foreign, and any applicable industry self-regulatory organization. 
 (j)    “HSR Act” means the United
States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder. 

(k)    “Knowledge of the Company” means the actual knowledge after reasonable inquiry of one or more of
Kevin J. O’Donnell, Ian D. Branagan, Ross A. Curtis, Aditya K. Dutt, James C. Fraser, Robert Qutub, Stephen H. Weinstein and Helen L. James. 

(l)    “Law” means any federal, state, local or foreign law, statute or ordinance, or any rule, code,
treaty, constitution, regulation, judgment, order, writ, injunction, ruling, decree, administrative interpretation or agency requirement of any Governmental Entity. 

(m)    “Lien” means any mortgage, deed of trust, pledge, hypothecation, security interest, encumbrance,
claim, escheat, encroachment, lien, charge of any kind, option, easement, purchase right, right of first refusal, right of pre-emption, conditional sale agreement, covenant, condition or other similar
restriction (including restrictions on transfer) or any agreement to create any of the foregoing. 

  
 17 

 (n)     “Registration Rights Agreement” means that
certain Registration Rights Agreement, dated as of the date hereof, the form of which is set forth as Schedule A. 
 
5.10    Captions. The article, section, paragraph and clause captions herein are for convenience of reference only, do not constitute part of this Agreement and will not be deemed to limit or otherwise affect any of
the provisions hereof. 
 5.11    Severability. If any provision of this
Agreement or the application thereof to any person (including the officers and directors of the parties hereto) or circumstance is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof,
or the application of such provision to persons or circumstances other than those as to which it has been held invalid or unenforceable, will remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long
as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and
equitable substitute provision to effect the original intent of the parties. 

5.12    No Third Party Beneficiaries. Nothing contained in this Agreement,
expressed or implied, is intended to confer upon any person other than the parties hereto (and their permitted assigns), any benefit, right or remedies other than the Indemnified Parties pursuant to Article IV. 

5.13    Public Announcements. Subject to each party’s disclosure obligations
imposed by law or regulation or the rules of any stock exchange upon which its securities are listed, each of the parties hereto will cooperate with each other in the development and distribution of all news releases and other public information
disclosures with respect to this Agreement and any of the transactions contemplated by this Agreement, and neither the Company nor the Purchaser will make any such news release or public disclosure without first consulting with the other, and, in
each case, also receiving the other’s consent (which shall not be unreasonably withheld or delayed) and each party shall coordinate with the party whose consent is required with respect to any such news release or public disclosure. 

5.14    Specific Performance. The parties agree that irreparable damage would
occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that, without the necessity of posting bond or other undertaking, the
parties shall be entitled to specific performance of the terms hereof, this being in addition to any other remedies to which they are entitled at law or equity, and in the event that any action or suit is brought in equity to enforce the provisions
of this Agreement, and no party will allege, and each party hereby waives, the defense or counterclaim that there is an adequate remedy at law. 

5.15    Termination. Prior to the Closing, this Agreement may only be terminated:

 (a)    by mutual written agreement of the Company and the Purchaser; or 

  
 18 

 (b)    by the Company or the Purchaser, upon written notice to the other
party, if the Closing has not occurred by January 31, 2019; provided, however that the right to terminate this Agreement pursuant to this Section 5.15(b) shall not be available to any party whose failure to fulfill any obligations under
this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to such date. 
 
5.16    Effects of Termination. In the event of any termination of this Agreement in accordance with Section 5.15, neither party (or any of its Affiliates) shall have any liability or obligation to the other (or
any of its Affiliates) under or in respect of this Agreement, except to the extent of (A) any liability arising from any breach by such party of its obligations of this Agreement arising prior to such termination and (B) any fraud or
intentional or willful breach of this Agreement. In the event of any such termination, this Agreement shall become void and have no effect, and the transactions contemplated hereby shall be abandoned without further action by the parties hereto, in
each case, except (x) as set forth in the preceding sentence and (y) that the provisions of Sections 3.1 (Confidentiality), 5.2 to 5.14 (Amendment; Waiver; Counterparts; Electronic Transmission;
Governing Law; Waiver of Jury Trial; Notices; Entire Agreement; Assignment; Interpretation; Other Definitions; Captions; Severability; No Third Party Beneficiaries; Public
Announcements; and Specific Performance) and Section 5.17 (Non-Recourse) shall survive the termination of this Agreement. 

5.17    Non-Recourse. This Agreement may
only be enforced against, and any claims or causes of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against the entities that are expressly
identified as parties hereto, including entities that become parties hereto after the date hereof, including permitted assignees and successors, or that agree in writing for the benefit of the Company to be bound by the terms of this Agreement
applicable to the Purchaser, and no former, current or future equityholders, controlling persons, directors, officers, employees, agents or Affiliates of any party hereto or any former, current or future equityholder, controlling person, director,
officer, employee, general or limited partner, member, manager, advisor, agent or Affiliate of any of the foregoing (each, a “Non-Recourse Party”) shall have any liability for any obligations
or liabilities of the parties to this Agreement or for any claim (whether in tort, contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated hereby or in respect of any representations made or alleged to be made
in connection herewith. Without limiting the rights of any party against the other parties hereto, in no event shall any party or any of its Affiliates seek to enforce this Agreement against, make any claims for breach of this Agreement against, or
seek to recover monetary damages from, any Non-Recourse Party. 

  
 19 

 IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly
authorized officers of the parties hereto as of the date first herein above written. 
  

			
	RENAISSANCERE HOLDINGS LTD.
		
	By:	 	/s/ Kevin O’Donnell
		 	Name: Kevin O’Donnell
		 	Title:   Chief Executive Officer and President

 [Signature Page to Investment Agreement] 

 IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly
authorized officers of the parties hereto as of the date first herein above written. 
  

			
	STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY
		
	By:	 	/s/ Paul J. Smith
		 	Paul J. Smith
		 	Executive Vice President – Property and Casualty

  

			
		
	By:	 	/s/ Jon C. Farney
		 	Jon C. Farney
		 	Senior Vice President, Treasurer and Chief Financial Officer

 [Signature Page to Investment Agreement] 

 SCHEDULE A 

Registration Rights Agreement 

[See Attached] 

 Exhibit A 

Form Of Opinion Of Conyers Dill & Pearman 
  

	 	•	 	 The Company is duly incorporated and existing under the laws of Bermuda in good standing (meaning solely that it
has not failed to make any filing with any Bermuda governmental authority or to pay any Bermuda government fee or tax which would make it liable to be struck off the Register of Companies and thereby cease to exist under the laws of Bermuda). The
Company possesses the capacity to sue and be sued in its own name under the laws of Bermuda. 

  

	 	•	 	 The issuance of Shares to be delivered to the Purchaser under Section 1.2 of the Agreement has been duly
authorized by all necessary corporate action on the part of the Company and, when issued and paid for in accordance with this Agreement, the Shares will be validly issued, fully paid and non-assessable
(meaning that no further sums are required to be paid by the holders thereof in connection with the issue thereof). 

  

	 	•	 	 No order, consent, approval, license, authorization or validation of or exemption by any government of public
body or authority of Bermuda or any sub-division thereof is required to authorize or is required in connection with the issuance, sale and delivery of the Shares to be delivered to the Purchaser under
Section 1.2 of the Agreement. 

  

	 	•	 	 The Company has the necessary corporate power and authority to enter into and perform its obligations under the
Agreement and the Registration Rights Agreement. The execution and delivery of the Agreement and the Registration Rights Agreement by the Company and the performance by the Company of its obligations thereunder will not violate the memorandum of
association or bye laws of the Company nor any applicable law, regulation, order or decree in Bermuda. 

  

	 	•	 	 The choice of the law of the State of New York as the governing law of the Agreement and the Registration Rights
Agreement is a valid choice of law and would be recognised and given effect to in any action brought before a court of competent jurisdiction in Bermuda, except for those laws (i) which such court considers to be procedural in nature;
(ii) which are revenue or penal laws or (iii) the application of which would be inconsistent with public policy, as such term is interpreted under the laws of Bermuda. The submission in the Agreement and the Registration Rights Agreement
to the jurisdiction of the state and federal courts in the Borough of Manhattan is valid and binding upon the Company. 

  

	 	•	 	 The courts of Bermuda would recognise as a valid judgment, a final and conclusive judgment in personam obtained
in the state and federal courts in the Borough of Manhattan against the Company based upon the Agreement and the Registration Rights Agreement under which a sum of money is payable (other than a sum of money payable in respect of multiple damages,
taxes or other charges of a like nature or in respect of a fine or other penalty) and would give a judgment based thereon provided that (a) such courts had proper jurisdiction over the parties subject to such judgment; (b) such courts did
not contravene the rules of natural justice of Bermuda; (c) such judgment was not obtained by fraud; (d) the enforcement of the judgment would not be contrary to the public policy of Bermuda; (e) no new admissible evidence relevant to
the action is submitted prior to the rendering of the judgment by the courts of Bermuda; and (f) there is due compliance with the correct procedures under the laws of Bermuda. 

 Exhibit B 

Form Of Opinion Of Willkie Farr & Gallagher LLP 
  

	 	•	 	 It is not necessary to register the Shares under the Securities Act in connection with the issuance, sale and
delivery of the Shares to be delivered to the Purchaser under Section 1.2 of the Agreement. 

  

	 	•	 	 Each of this Agreement and the Registration Rights Agreement, to the extent that execution and delivery thereof
are governed by New York law, has been duly executed and delivered and constitutes a valid and legally binding agreement of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by
bankruptcy, insolvency, reorganization or other similar laws relating to or affecting the enforcement of creditors’ rights generally and by general principles of equity.EX-10.2

 EXECUTION VERSION 

Exhibit 10.2 
  

 
 REGISTRATION RIGHTS AGREEMENT 

Dated as of October 30, 2018 
  

 

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
	 ARTICLE I REGISTRATION RIGHTS
	  	 	1	 
		
	 1.1      Shelf
Registrations.
	  	 	1	 
	 1.2      Demand
Registrations.
	  	 	3	 
	 1.3      
Inclusion of Other Securities; Priority
	  	 	4	 
	 1.4      
Restrictions on Registration.
	  	 	5	 
	 1.5      Piggyback
Registrations.
	  	 	6	 
	 1.6      Holdback
Agreement.
	  	 	8	 
	 1.7      Registration
Procedures
	  	 	9	 
	 1.8      Registration
Expenses.
	  	 	13	 
	
1.9      Indemnification.
	  	 	14	 
	 1.10    
Participation in Underwritten Registrations
	  	 	16	 
	 1.11    Rule 144 and 144A
Reporting.
	  	 	16	 
	 1.12    Miscellaneous.
	  	 	17	 
	 1.13    Subject to Transfer
Restrictions
	  	 	17	 
		
	 ARTICLE II COVENANTS
	  	 	18	 
		
	 2.1      Transfer
Restrictions.
	  	 	18	 
	 2.2      Standstill
	  	 	18	 
	 2.3      Ownership
Threshold
	  	 	20	 
	 2.4      Listing
	  	 	20	 
	 2.5      Private Sale and
Legends
	  	 	20	 
		
	 ARTICLE III [INTENTIONALLY OMITTED]
	  	 	21	 
		
	 ARTICLE IV MISCELLANEOUS
	  	 	21	 
		
	 4.1      Term
	  	 	21	 
	 4.2      Notices
	  	 	21	 
	 4.3      Investor
Actions
	  	 	22	 
	 4.4      No
Partnership
	  	 	22	 
	 4.5      Memorandum of
Association
	  	 	22	 
	 4.6      Amendments and
Waivers
	  	 	22	 
	 4.7      
Assignment of Registration Rights
	  	 	23	 
	 4.8      Assignment
	  	 	23	 
	 4.9      Severability
	  	 	23	 
	 4.10    Counterparts
	  	 	23	 
	 4.11    Entire Agreement
	  	 	23	 
	 4.12    
Governing Law; Jurisdiction; Waiver of Jury Trial; Agent for Service of Process.
	  	 	24	 
	 4.13    Specific Performance
	  	 	24	 
	 4.14    No Third Party
Beneficiaries
	  	 	24	 
	 4.15    Defined Terms
	  	 	24	 
	 4.16    Interpretation
	  	 	29	 
	 4.17    Further Assurances
	  	 	30	 

  
 -i- 

 This REGISTRATION RIGHTS AGREEMENT, dated as of October 30, 2018 (this
“Agreement”) and effective as of the Closing Date, is made between RenaissanceRe Holdings Ltd., a company formed under the laws of Bermuda (together with its successors and permitted assigns, the
“Company”), and Tokio Marine & Nichido Fire Insurance Co., Ltd., a Japanese joint stock corporation (the “Parent”). 
  

	A.	 On the date hereof (the “Signing Date”), the Company, the Parent and Tokio Marine Holdings,
Inc., solely for purposes of Section 5.14 and Article XI of the Stock Purchase Agreement, entered into the Stock Purchase Agreement, dated as of the Signing Date (the “Stock Purchase Agreement”), providing for, among other
things, the issuance to the Parent of certain securities of the Company. 

  

	B.	 On the Closing Date, pursuant to the Stock Purchase Agreement, the Parent will have acquired from the Company a
number of Company Common Shares equal to the RenRe Share Amount. 

  

	C.	 The Company and the Parent desire to establish in this Agreement certain terms and conditions concerning the
Parent’s and other Investors’ relationships with and investments in the Company, including the registration rights for Registrable Securities set forth in this Agreement. 

 

	D.	 Capitalized terms used in this Agreement are used as defined in Section 4.15.

 Now, therefore, the parties hereto agree as follows: 

ARTICLE I 

REGISTRATION RIGHTS 
 
1.1    Shelf Registrations. 
 (a)    Shelf Registration. No later than the date
that is ten (10) days prior to the Restricted Period Termination Date, in the case of a Shelf Registration Statement that is an Automatic Shelf Registration Statement, or sixty (60) days prior to the Restricted Period Termination Date, in
the case of a Shelf Registration Statement other than an Automatic Shelf Registration Statement, the Company shall prepare and file with the SEC a Shelf Registration Statement covering all Registrable Securities held by the Investors pursuant to a
Shelf Registration. If permitted under the Securities Act, such Shelf Registration Statement shall be an Automatic Shelf Registration Statement. The Shelf Registration shall provide for the resale of such Registrable Securities from time to time by
and pursuant to any method or combination of methods legally available to the Investors (including, without limitation, an underwritten offering, a direct sale to purchasers, a sale to or through brokers, dealers or agents, a sale over the internet,
block trades, derivative transactions with third parties, sales in connection with short sales and other hedging transactions). The Company shall comply with the applicable provisions of the Securities Act with respect to the disposition of all
Registrable Securities covered by such Shelf Registration Statement in accordance with the methods of disposition of which the Parent and the other Investors have notified the Company prior to the filing by the Company of the applicable Shelf
Registration Statement. 

  
 -1- 

 (b)    Effectiveness. The Company shall use its commercially
reasonable efforts to (i) cause the Shelf Registration Statement filed pursuant to Section 1.1(a) to be declared effective by the SEC or otherwise become effective under the Securities Act as promptly as practicable
after the filing thereof and (ii) keep such Shelf Registration Statement continuously effective and in compliance with the Securities Act and useable for the resale of Registrable Securities covered by such Shelf Registration Statement,
including by filing successive replacement or renewal Shelf Registration Statements upon the expiration of such Shelf Registration Statement, until the earlier of (a) such time as there are no Registrable Securities remaining and (b) the
termination of this Agreement. 
 (c)    Additional Selling Shareholders. At any time and from time to time when
a Shelf Registration Statement is effective, if the Parent or any other Investor requests that the Parent or any other Investor be added as a selling shareholder in such Shelf Registration Statement, the Company shall as promptly as practicable
amend or supplement the Shelf Registration Statement to cover such additional Investor. 
 (d)    Right to Effect
Shelf Take-Down. The Parent and each other Investor shall be entitled, at any time and from time to time when a Shelf Registration Statement is effective, subject to Section 2.1, to sell any or all of the Registrable
Securities covered by such Shelf Registration Statement (a “Shelf Take-Down”). 

(e)    Underwritten Shelf Take-Downs. The Parent or any other Investor intending to effect a Shelf Take-Down shall
be entitled to request, by written notice to the Company (an “Underwritten Shelf Take-Down Notice”), that the Shelf Take-Down be an underwritten offering (an “Underwritten Shelf Take-Down”). The Underwritten Shelf
Take-Down Notice shall specify the number of Registrable Securities intended to be offered and sold by the Parent and/or other Investor(s) pursuant to the Underwritten Shelf Take-Down. The Company shall amend or supplement the Shelf Registration as
may be necessary in order to enable such Registrable Securities to be distributed pursuant to the Underwritten Shelf Take-Down. The Company will pay all Registration Expenses incurred in connection with any registration or underwritten offering
requested in accordance with this Agreement. The Company shall not be required to facilitate an Underwritten Shelf Take-Down unless the aggregate gross proceeds from such offering are reasonably expected to be at least the lesser of
(x) one-hundred million dollars ($100 million) and (y) the aggregate gross proceeds from an Underwritten Shelf Take-Down (not less than $50 million) of the total number of Registrable Securities held by the Parent or any other Investors;
and shall not be required to effect more than two (2) Underwritten Shelf Take-Downs under this Agreement. 

(f)    Selection of Underwriters. In connection with any such underwritten offering, the Parent or any other
Investor requesting such underwritten offering shall have the right to select the investment banking firm(s) and manager(s) to administer such underwritten offering, subject to the approval of the Company (which approval shall not be unreasonably
withheld, conditioned or delayed). For such underwritten offering, the Company will have the right to appoint one co-lead manager that shall not serve in the capacity as a bookrunning underwriter. 

  
 -2- 

 (g)    Non-Underwritten Shelf
Take-Down. If the Parent or any other Investor desires to initiate an offering or sale of all or part of the Parent’s or any other Investor’s Registrable Securities that does not constitute an Underwritten Shelf Take-Down (a “Non-Underwritten Shelf Take-Down”), the Parent or such other Investor shall so indicate in a written notice (a “Non-Underwritten Shelf Take-Down
Notice”) delivered to the Company no later than three (3) Business Days (or in the event any amendment or supplement to a Shelf Registration Statement is necessary, no later than ten (10) Business Days) prior to the expected date
of such Non-Underwritten Shelf Take-Down, which request shall include (i) the total number of Registrable Securities expected to be offered and sold in such
Non-Underwritten Shelf Take-Down, (ii) the expected plan of distribution of such Non-Underwritten Shelf Take-Down and (iii) the action or actions required
(including the timing thereof) in connection with such Non-Underwritten Shelf Take-Down (including the delivery of one or more share certificates representing Registrable Securities to be sold in such Non-Underwritten Shelf Take-Down), and, to the extent necessary, the Company shall file and effect an amendment or supplement to its applicable Shelf Registration Statement for such purpose as soon as practicable
after receipt of such Non-Underwritten Shelf Take-Down Notice. 

1.2    Demand Registrations. 

(a)    Right to Demand Registrations. At any time following the Restricted Period Termination Date, if a Shelf
Registration Statement is not available for an Underwritten Shelf Take-Down, the Parent or any other Investor may, by providing written notice to the Company, request to sell all or a portion of the Registrable Securities pursuant to a Registration
Statement separate from a Shelf Registration Statement (a “Demand Registration”). Each request for a Demand Registration (a “Demand Registration Request”) shall specify the number of Registrable Securities intended
to be offered and sold by the Parent and any other Investors pursuant to the Demand Registration and the intended method of distribution thereof, including whether it is intended to be an underwritten offering. As promptly as practicable and no
later than ten (10) Business Days after receipt of a Demand Registration Request, the Company shall register all Registrable Securities that have been requested to be registered in the Demand Registration Request. The Company shall use its
commercially reasonable efforts to cause the Registration Statement filed pursuant to this Section 1.2(a) to be declared effective by the SEC or otherwise become effective under the Securities Act as promptly as reasonably
practicable after the filing thereof; provided, however, that the Registration Statement filed pursuant to this Section 1.2(a) need not be declared effective prior to the Restricted Period Termination Date. A
Demand Registration shall be effected by way of a Registration Statement on Form S-3 or any similar short-form registration statement to the extent the Company is permitted to use such form at such time,
and may be effected through an existing registration statement that is already effective under the Securities Act, or through a post-effective amendment or supplement to any such Registration Statement or other registration statement. 

(b)    Number of Demand Registrations. The Parent and the other Investors shall be collectively entitled to request
up to a total of two (2) Demand Registrations (each of which shall, if it is an underwritten registration, reduce the number of available Underwritten Shelf Take-Downs pursuant to Section 1.1(e), and, vice versa, each
Underwritten Shelf Take-Down shall reduce the number of available Demand Registrations that are underwritten registrations); provided, however, that a registration shall not count as a Demand Registration for this purpose

  
 -3- 

 
unless and until the Parent and the other Investors are able to register and sell at least 75% of the Registrable Securities requested to be included in such registration; provided, that
the Company shall not be required to comply with a Demand Registration unless the aggregate gross proceeds from such offering are reasonably expected to be at least the lesser of (x) one-hundred million dollars ($100 million) and (y) the
aggregate gross proceeds from such offering of the total number of Registrable Securities held by the Parent or any other Investors. 

(c)    Withdrawal. An Investor may, by written notice to the Company, withdraw its Registrable Securities from a
Demand Registration at any time prior to the effectiveness of the applicable Registration Statement. Upon receipt of notices from all applicable Investors to such effect, the Company shall cease all efforts to seek effectiveness of the applicable
Registration Statement, unless the Company intends to effect a primary offering of securities pursuant to such Registration Statement. 

(d)    Selection of Underwriters. If a Demand Registration is an underwritten offering, the Parent or any other
Investor requesting such underwritten offering shall have the right to select the investment banking firm(s) and manager(s) to administer such underwritten offering, subject to the approval of the Company (which approval shall not be unreasonably
withheld, conditioned or delayed). For such underwritten offering, the Company will have the right to appoint one co-lead manager that shall not serve in the capacity as a bookrunning underwriter. 

1.3    Inclusion of Other Securities; Priority. The Company shall not include in
any Demand Registration or Shelf Take-Down any securities that are not Registrable Securities without the prior written consent of the Investors participating in such Demand Registration or Shelf Take-Down (such consent not to be unreasonably
withheld, conditioned or delayed). If a Demand Registration or Shelf Take-Down involves an underwritten offering and the managing underwriters of such offering advise the Company and the Investors in writing that, in their opinion, the number of
Equity Securities proposed to be included in such Demand Registration or Underwritten Shelf Take-Down, including all Registrable Securities and all other Equity Securities proposed to be included in such offering, exceeds the number of Equity
Securities that can reasonably be expected to be sold in such offering without adversely affecting the success of the offering (including the price, timing or distribution of the securities to be sold in such offering), the Company shall include in
such Demand Registration or Underwritten Shelf Take-Down: (i) first, the Registrable Securities proposed to be sold by Investors (and, if applicable, Other Stockholders) in such offering; and
(ii) second, any Equity Securities proposed to be included therein by any other Persons (including Equity Securities to be sold for the account of the Company and/or any other holders of Equity Securities), allocated, in the case of this
clause (ii), among such Persons in such manner as the Company may determine. If more than one Investor (and, if applicable, Other Stockholders) is participating in such Demand Registration or Underwritten Shelf Take-Down and the managing
underwriters of such offering determine that a limited number of Registrable Securities may be included in such offering without reasonably being expected to adversely affect the success of the offering (including the price, timing or distribution
of the securities to be sold in such offering), then the Registrable Securities that are included in such offering shall be allocated pro rata among the participating Investors (and, if applicable, Other Stockholders) on the basis of the
number of Registrable Securities initially requested to be sold by each such Investor (and, if applicable, Other Stockholders) in such offering. 

  
 -4- 

 1.4    Restrictions on
Registration. 
 (a)    Right to Defer or Suspend Registration. In the event that the Company determines in
good faith that any one or more of the following circumstances exist, the Company may, at its option, (x) defer, suspend or delay any Demand Registration or (y) require the Parent and the other Investors to suspend any offerings of
Registrable Securities (including any Underwritten Shelf Take-Down) pursuant to a Registration Statement for the periods specified: 

(i)    if the Company is subject to any of its customary suspension or blackout periods, for all or part
of such period; 
 (ii)    if the Company reasonably believes that an offering would (A) be
expected to materially impede, delay or interfere with, or require premature disclosure of, any material financing, offering, acquisition, merger, corporate reorganization, segment reclassification or discontinuance of operations that is required to
be reflected in pro forma or restated financial statements that amends historical financial statements of the Company, or other significant transaction or any negotiations, discussions or pending proposals with respect thereto, involving the Company
or any of its Subsidiaries or (B) require the Company, under applicable securities laws and other laws, to make disclosures of material non-public information that would not otherwise be required to be
disclosed at that time and the Company believes in good faith that such disclosures at that time would have a material and adverse effect on the Company; provided, that the exception in clause (A) above shall continue to apply only
during the time that such expectation exists, and the exception in clause (B) above shall continue to apply only during the time that such material non-public information has not been disclosed and
remains material; provided, further, that upon disclosure of such material non-public information, unless clause (A) above applies, the Company shall (x) notify the Parent and the other
Investors whose Registrable Securities are included in the Registration Statement; (y) terminate any deferment or suspension it has put into effect; and (z) take such actions necessary to permit registered sales of Registrable Securities
as required or contemplated by this Agreement, including, if necessary, preparation and filing of a post-effective amendment or prospectus supplement so that the Registration Statement and any prospectus forming a part thereof will not include an
untrue statement of material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances in which they were made, not misleading; and 

(iii)    if any such offering would violate applicable Law. 

(b)    Limitation on Deferrals and Suspensions. The Company shall not be permitted to defer registration or require
the Parent and the other Investors to suspend an offering pursuant to Section 1.4(a)(ii) if the duration of any such deferral or suspension would individually exceed sixty (60) consecutive days or if the duration of
all such deferrals or suspensions would in the aggregate exceed one hundred twenty (120) days in any twelve (12) month period. 

  
 -5- 

 (c)    Withdrawal. If the Company delays or suspends a Demand
Registration, the Investor that initiated such Demand Registration shall be entitled to withdraw its Demand Registration Request and, if it does so, such Demand Registration Request shall not count against the limitation on the number of such
Investor’s Demand Registrations set forth in Section 1.2(b). 

1.5    Piggyback Registrations. 

(a)    Right to Piggyback. Whenever the Company proposes to register any Equity Securities under the Securities Act
(other than a registration (i) pursuant to a Registration Statement on Form S-8 (or other registration solely relating to an offering or sale to employees or directors of the Company pursuant to any
employee share plan or other employee benefit arrangement), (ii) pursuant to a Registration Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145 under the
Securities Act or any successor rule thereto), (iii) in connection with any dividend or distribution reinvestment or similar plan or (iv) pursuant to a registration in which the Company is offering to exchange its own securities for other
securities), whether for its own account or for the account of one or more shareholders of the Company (other than the Investors) (a “Piggyback Registration”), the Company shall give prompt written notice to each Investor (which
notice shall be held in confidence by the Investor until the offering is publicly disclosed) of its intention to effect such a registration (but in no event less than ten (10) Business Days prior to the proposed date of filing of the applicable
Registration Statement (or, in connection with an offering that the Company reasonably determines is necessary to cover capital losses or adverse reserve developments as a result of claims arising from a severe natural disaster or catastrophe or
another event that is reasonably expected to reduce the Company’s shareholders’ equity by more than 10%, such fewer number of Business Days as the Company shall determine in its reasonable discretion)) and, subject to
Sections 1.5(b), 1.5(c) and 2.1, shall include in such Registration Statement and in any offering of Equity Securities to be made pursuant to such Registration Statement that number of Registrable Securities requested to be
sold in such offering by such Investor for the account of such Investor, provided that the Company has received a written request for inclusion therein from such Investor no later than five (5) Business Days (or, in connection with an
offering that the Company reasonably determines is necessary to cover capital losses or adverse reserve developments as a result of claims arising from a severe natural disaster or catastrophe or another event that is reasonably expected to reduce
the Company’s shareholders’ equity by more than 10%, such fewer number of Business Days as the Company shall determine in its reasonable discretion) after the date on which the Company has given notice of the Piggyback Registration to
Investors. The Company may terminate, delay or withdraw a Piggyback Registration prior to the effectiveness of such registration at any time in its sole discretion and, thereupon, (x) in the case of a determination to terminate or withdraw any
registration, the Company shall be relieved of its obligation to register any Registrable Securities under this Section 1.5 in connection with such registration and (y) in the case of a determination to delay
registration, the Company shall be permitted to delay registering any Registrable Securities under this Section 1.5 for the same period as the delay in registering the other equity securities covered by such registration.
If a Piggyback Registration is effected pursuant to a Registration Statement on Form S-3 or the then-appropriate form for an offering to be made on a delayed or continuous basis pursuant to

  
 -6- 

 
Rule 415 under the Securities Act or any successor rule thereto (a “Piggyback Shelf Registration Statement”), the Investors shall be notified by the Company of and shall
have the right, but not the obligation, to participate in any offering pursuant to such Piggyback Shelf Registration Statement (a “Piggyback Shelf Take-Down”), subject to the same limitations that are applicable to any other
Piggyback Registration as set forth above. 
 (b)    Priority on Primary Registrations. If a Piggyback
Registration or Piggyback Shelf Take-Down is initiated as a primary underwritten offering on behalf of the Company and the managing underwriters of the offering advise the Company in writing that, in their opinion, the number of Equity Securities
proposed to be included in such offering, including all Registrable Securities and all other Equity Securities proposed to be included in such offering, exceeds the number of Equity Securities that can reasonably be expected to be sold in such
offering without adversely affecting the success of the offering (including the price, timing or distribution of the securities to be sold in such offering), the Company shall include in such Piggyback Registration or Piggyback Shelf Take-Down:
(i) first, the Equity Securities that the Company proposes to sell in such offering; and (ii) second, the Registrable Securities requested to be included in such registration by the Parent or any other Investor (and, if
applicable, Other Stockholders), allocated, in the case of this clause (ii), pro rata among such Investors (and, if applicable, Other Stockholders) on the basis of the number of Registrable Securities initially
proposed to be included by each such Investor (and, if applicable, Other Stockholders) in such offering. 

(c)    Priority on Secondary Registrations. If a Piggyback Registration or a Piggyback Shelf Take-Down is initiated
as an underwritten offering other than on behalf of the Company, and the managing underwriters of the offering advise the Company in writing that, in their opinion, the number of Equity Securities proposed to be included in such offering, including
all Registrable Securities and all other Equity Securities requested to be included in such offering, exceeds the number of Equity Securities which can reasonably be expected to be sold in such offering without adversely affecting the success of the
offering (including the price, timing or distribution of the securities to be sold in such offering), the Company shall include in such Piggyback Registration or Piggyback Shelf Take-Down: (i) first, the Registrable Securities requested
to be included in such registration by the Parent or any other Investor (and, if applicable, Other Stockholders), allocated, in the case of this clause (i), pro rata among such Investors (and, if applicable, Other
Stockholders) on the basis of the number of Registrable Securities initially proposed to be included by each such Investor (and, if applicable, Other Stockholders) in such offering; and (ii) second, any Equity Securities that the Company
proposes to sell in such offering. 
 (d)    Selection of Underwriters. In any Piggyback Registration or
Piggyback Shelf Take-Down, including if initiated as a primary underwritten offering on behalf of the Company or another securityholder, the Company shall have the right to select the investment banking
firm(s) to act as the underwriters (including managing underwriter(s)) in connection with such offering. 

  
 -7- 

 1.6    Holdback Agreement. 

(a)    For so long as Parent and any other Investor, individually or together, holds or Beneficially Owns at least five
percent (5%) of the issued and outstanding Company Common Shares on an as-converted basis, each Investor agrees that in connection with any registered underwritten offering of Company Common Shares, and upon
request from the managing underwriter(s) for such offering, such Investor shall not, without the prior written consent of such managing underwriter(s), during such period as is reasonably requested by the managing underwriter(s) (which period shall
in no event be longer than three (3) days prior to and ninety (90) days after the launch of such offering), Transfer any Registrable Securities and, regardless of whether Parent and any other Investor, individually or together, holds or
Beneficially Owns at least five percent (5%) of the issued and outstanding Company Common Shares on an as-converted basis, exercise any rights under this Agreement to a Demand Registration or Underwritten
Shelf Take-Down during such period, as well as during the period between the date it receives notice of an underwritten offering of Company Common Shares and the start of such period. The foregoing provisions of this
Section 1.6(a) shall not apply to offers or sales of Registrable Securities that are included in an offering pursuant to Section 1.1, 1.2 or 1.5 of this Agreement and shall be
applicable to the Investors only if, for so long as and to the extent that the Company, the directors and executive officers of the Company and each selling shareholder included in such offering are subject to the same restrictions. Each Investor
agrees to execute and deliver such customary agreements as may reasonably be requested by the managing underwriter(s) that are consistent with the foregoing provisions of this Section 1.6(a) and are necessary to give
further effect thereto; provided, that the terms of such agreements shall not be more restrictive than the restrictions to which the directors and executive officers of the Company are subject. 

(b)    To the extent requested by the managing underwriter(s) for the applicable offering, the Company and its directors
and executive officers shall not effect any sale registered under the Securities Act or other public distribution of Equity Securities during the period commencing three (3) days prior to and ending ninety (90) days after the launch of an
underwritten offering pursuant to Section 1.1, 1.2 or 1.5 of this Agreement, other than a registration (i) pursuant to a Registration Statement on Form S-8 (or
other registration solely relating to an offering or sale to employees or directors of the Company pursuant to any employee share plan or other employee benefit arrangement), (ii) pursuant to a Registration Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule thereto), (iii) pursuant to a registration in which the Company is offering to exchange its own
securities for other securities, (iv) in connection with any dividend or distribution reinvestment or similar plan or (v) in connection with an offering that the Company reasonably determines is necessary to cover capital losses or adverse
reserve developments as a result of claims arising from a severe natural disaster or catastrophe or another event that is reasonably expected to reduce the Company’s shareholders’ equity by more than 10% occurring after the launch of an
underwritten offering pursuant to Section 1.1, 1.2 or 1.5 of this Agreement. 

  
 -8- 

 1.7    Registration Procedures.

 (a)    In connection with the registration obligations of the Company pursuant to and in accordance with this
Agreement, the Company will use its commercially reasonable efforts to effect the registration and sale of Registrable Securities in accordance with the methods of disposition thereof, of which the Parent and the other Investors have notified the
Company prior to the filing by the Company of the applicable Registration Statement, as promptly as reasonably practicable, and the Company shall: 

(i)    prepare and file with the SEC a Registration Statement with respect to such Registrable Securities,
cooperate with underwriters’ counsel in an underwritten offering in connection with all required filings with FINRA and thereafter use its commercially reasonable efforts to cause such Registration Statement to become effective upon filing but
in any event as soon as reasonably practicable after the filing of such Registration Statement (provided, however, that a Registration Statement filed pursuant to Section 1.2(a) need not be declared effective
prior to the Restricted Period Termination Date); provided, that before filing a Registration Statement or any amendments or supplements thereto (other than reports required to be filed by it under the Exchange Act that are incorporated or
deemed to be incorporated by reference into the Registration Statement), the Company will furnish to the Parent and the other Investors copies of all documents proposed to be filed. In the case of a Registration Statement pursuant to
Section 1.1 or 1.2, if the Parent informs the Company that it has any objections to the filing of such Registration Statement, amendment or supplement, the Company will not file such Registration Statement, amendment
or supplement. In the case of a Registration Statement pursuant to Section 1.5, the Company will not file any Registration Statement or amendment or supplement to such Registration Statement to which the Parent will have
reasonably objected on the grounds that such amendment or supplement does not comply in all material respects with the requirements of the Securities Act or of the rules or regulations thereunder, provided that the Company shall have the opportunity
to make such Registration Statement or amendment or supplement thereto compliant in all material respects with such requirements and thereafter file such Registration Statement or amendment or supplement; 

(ii)    use commercially reasonable efforts to prepare and file with the SEC such amendments and
supplements to any Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement effective until all of the Registrable Securities covered by such Registration Statement have been
disposed of and comply with the applicable requirements of the Securities Act with respect to the disposition of the Registrable Securities covered by such Registration Statement; 

(iii)    furnish to the Parent and the other Investors, without charge, such number of conformed copies of
such Registration Statement and of each post-effective amendment thereto, and deliver, without charge, such number of copies of each preliminary prospectus, final prospectus, all exhibits and other documents
filed therewith and such other documents as the Parent and the other Investors may reasonably request including in order to facilitate the disposition of the Registrable Securities owned by it or any other Investor; 

  
 -9- 

 (iv)    use its commercially reasonable efforts to
register or qualify such Registrable Securities under such other securities or blue sky laws of such jurisdictions as the Parent and the other Investors reasonably request in writing; provided, that the Company shall not be required to
qualify generally to do business, subject itself to taxation or consent to general service of process in any jurisdiction where it would not otherwise be required to do so but for its obligations pursuant to this
Section 1.7(a)(iv); 
 (v)    promptly as reasonably practicable notify the
Parent and the other Investors, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, upon discovery that, or upon the discovery of the happening of any event as a result of which, the prospectus
contains an untrue statement of a material fact or omits any fact necessary to make the statements therein not misleading in the light of the circumstances under which they were made, and, as promptly as practicable, prepare and furnish to the
Parent and the other Investors a reasonable number of copies of a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain an untrue statement of a
material fact or omit to state any fact necessary to make the statements therein not misleading in the light of the circumstances under which they were made; provided, that any Investor receiving information pursuant to this
Section 1.7(a)(v) shall hold any of the information communicated pursuant to this Section 1.7(a)(v) in confidence until is publicly disclosed; 

(vi)    promptly as reasonably practicable notify the Parent and the other Investors (A) when the
prospectus or any prospectus supplement or post-effective amendment has been filed and, with respect to such Registration Statement or any post-effective amendment, when the same has become effective, (B) of any request by the SEC for
amendments or supplements to such Registration Statement or to amend or to supplement such prospectus or for additional information, (C) of the issuance by the SEC of any stop order suspending the effectiveness of such Registration Statement or
the initiation of any proceedings for such purpose and (D) of the receipt by the Company or its legal counsel of any notification with respect to the suspension of the qualification of any of the Registrable Securities for sale in any
jurisdiction or the initiation or, to the knowledge of the Company, threatening of any proceeding for such purpose; 

(vii)    use commercially reasonable efforts to cause all such Registrable Securities to be listed on each
securities exchange, if any, on which similar securities issued by the Company are then listed or, if no similar securities issued by the Company are then listed on any securities exchange, use its commercially reasonable efforts to cause all such
Registrable Securities to be listed on such securities exchange reasonably selected by the Company; 

(viii)    enter into such customary agreements (including underwriting agreements in form, scope and
substance as is acceptable to the Company acting reasonably, which shall not include any “clear market” restrictions on the 

  
 -10- 

 
Company) and take all such appropriate and reasonable other actions as the Parent, the Investors or the underwriters, if any, reasonably request in order to expedite or facilitate the
disposition of such Registrable Securities ̧ including making members of senior management of the Company available to participate on a reasonable basis in “road show” and other customary marketing activities reasonably requested by
the managing underwriter(s), in each case consistent, to the extent commercially reasonable, with the historical practices of the Company for an underwritten offering by the Company having an aggregate offering size comparable to such offering; 

(ix)    if such offering is an underwritten offering, make available upon reasonable notice at reasonable
times and for reasonable periods for inspection by the Parent, the other Investors, any underwriter participating in any disposition pursuant to such Registration Statement and any counsel, accountant or other agent retained by the Parent and the
other Investors or any such underwriter, all financial and other records, pertinent corporate documents of the Company related to the Company and its business as will be reasonably necessary and requested by such Investor(s) or underwriters to
enable them to reasonably exercise their due diligence responsibilities, provided that each of the Parent, the other Investors, any such underwriter and any counsel, accountant or other agent retained by the Parent, the other Investors or any
such underwriter will, if requested, enter into a confidentiality agreement satisfactory to the Company; 

(x)    otherwise use its commercially reasonable efforts to comply with all applicable rules and
regulations of the SEC, and make available to its security holders, as soon as reasonably practicable, an earnings statement in a form that satisfies the provisions of Section 11(a) of the U.S. Securities Act and Rule 158 thereunder, which
requirement shall be deemed satisfied if the Company timely files complete and accurate information on Forms 10-K, 10-Q and 8-K
under the Exchange Act and otherwise complies with Rule 158 under the Securities Act or any successor rule thereto; 

(xi)    in the event of the issuance of any stop order suspending the effectiveness of a Registration
Statement, or of any order suspending or preventing the use of any related prospectus or ceasing trading of any securities included in such Registration Statement for sale in any jurisdiction, use commercially reasonable efforts promptly to obtain
the withdrawal of such order at the earliest practicable time; 
 (xii)    if such offering is an
underwritten offering, use commercially reasonable efforts to furnish to the Parent, each underwriter and the other Investors one or more comfort letters, addressed to the underwriters, the Parent and the Investors, dated the effective date of, or
the date of the final receipt issued for, such Registration Statement (the date of the closing under the underwriting agreement for such offering), signed by the Company’s independent public accountants in customary form and covering such
matters of the type customarily covered by comfort letters in similar underwritten offerings; 

  
 -11- 

 (xiii)    if such offering is an underwritten offering,
use commercially reasonable efforts to provide legal opinions of the Company’s outside counsel, addressed to the underwriters, dated the effective date of, or the date of the final receipt issued for, such Registration Statement (the date of
the closing under the underwriting agreement for such offering), each amendment and supplement thereto, with respect to the Registration Statement, each amendment and supplement thereto (including the preliminary prospectus) and such other
documents relating thereto in customary form and covering such matters of the type customarily covered by legal opinions of such nature; 

(xiv)    make available to the Parent and the other Investors each item of correspondence from the SEC or
the staff of the SEC and each item of correspondence written by or on behalf of the Company to the SEC or the staff of the SEC, in each case solely relating to such Registration Statement; and 

(xv)    use commercially reasonable efforts to procure the cooperation of the Company’s transfer
agent in settling any Transfer of Registrable Securities, including (A) with respect to the transfer of any physical share certificates representing common shares into book-entry form in accordance with any procedures reasonably requested by
the Parent or the Investors or the underwriters, and (B) to the extent such Registrable Securities are subject to a restrictive legend, by removing such legend (or eliminating or terminating such comparable notations or arrangements on
securities held in book-entry form) and, if required by the Company’s transfer agent, delivering an opinion of the Company’s counsel that the restriction referenced in such legend (or such notations or arrangements) is no longer required
in order to ensure compliance with the Securities Act. 
 (b)    The Company agrees not to file or make any amendment to
any Registration Statement with respect to any Registrable Securities, or any amendment of or supplement to the prospectus used in connection therewith, that refers to the Parent or any other Investor by name, or otherwise identifies the Parent or
any other Investor as the holder of any securities of the Company, without the consent of the Parent (any such consent to be binding on each other Investor), such consent not to be unreasonably withheld, conditioned or delayed, unless and to the
extent such disclosure is required by applicable Law. 
 (c)    The Company may require the Parent and any other
Investor to furnish the Company with such information regarding the Parent and such other Investor and pertinent to the disclosure requirements relating to the registration and the distribution of such securities as the Company may from time to time
reasonably request in writing. If within ten (10) Business Days (or, in the case of a Piggyback Registration in connection with an offering that the Company reasonably determines is necessary to cover capital losses or adverse reserve
developments as a result of claims arising from a severe natural disaster or catastrophe, such fewer number of Business Days as the Company shall determine in its reasonable discretion) of the receipt of such a written request from the Company, the
Parent or any other Investor fails to provide to the Company any information relating to the Parent or such Investor, as applicable, that is required by applicable law to be disclosed in the Registration Statement, the Company may exclude the
Parent’s and such Investor’s, as applicable, Registrable Securities from such Registration Statement. 

  
 -12- 

 (d)    The Parent agrees that, upon receipt of any notice from the
Company of the happening of any event of the kind described in Section 1.7(a)(v), 1.7(a)(vi)(B), 1.7(a)(vi)(C) or 1.7(a)(vi)(D) hereof, to the extent that such event requires the discontinuance of the
disposition of Registrable Securities covered by a Registration Statement or the related prospectus and such notice reasonably requests such discontinuance, that the Parent shall discontinue, and shall use commercially reasonable efforts to cause
each Investor to discontinue, disposition of any Registrable Securities covered by such Registration Statement or the related prospectus until receipt of the copies of the supplemented or amended prospectus contemplated by
Section 1.7(a)(iii) hereof, which supplement or amendment shall be prepared and furnished as soon as practicable, or until the Parent and the other Investors are advised in writing by the Company that the use of the
applicable prospectus may be resumed, and has received copies of any amended or supplemented prospectus or any additional or supplemental filings which are incorporated, or deemed to be incorporated, by reference in such prospectus (such period
during which disposition is discontinued being an “Interruption Period”) and, if requested by the Company, the Parent shall use its commercially reasonable efforts to, and shall use its commercially reasonable efforts to cause
each of the other Investors to, destroy or return to the Company all copies then in its possession, other than permanent file copies then in such holder’s possession, of the prospectus covering such Registrable Securities at the time of receipt
of such request. As soon as practicable (and in any event no later than two (2) Business Days) after the Company has determined that the use of the applicable prospectus may be resumed, the Company shall provide written notice to the Parent and
the other Investors. In the event the Company invokes an Interruption Period hereunder, as soon as practicable (and in any event no later than two (2) Business Days) after the need for the Company to continue the Interruption Period ceases for
any reason, the Company shall provide written notice to the Parent and the other Investors that such Interruption Period is no longer applicable. Notwithstanding anything in this paragraph to the contrary, no Interruption Period shall exceed sixty
(60) days and, in any calendar year, no more than one hundred twenty (120) days in the aggregate may be part of an Interruption Period. 

1.8    Registration Expenses. 

(a)    The Company shall pay directly or promptly reimburse all costs, fees and expenses (other than Selling Expenses)
incident to the Company’s performance of or compliance with this Agreement, including, without limitation, (i) all SEC, FINRA and other registration and filing fees; (ii) all fees and expenses associated with filings to be made with,
or the listing of any Registrable Securities on, any securities exchange or over-the-counter trading market on which the Registrable Securities are to be listed or
quoted; (iii) all fees and expenses of complying with securities and blue sky laws (including fees and disbursements of counsel in connection therewith); (iv) all printing, messenger, telephone and delivery expenses (including the cost of
distributing prospectuses in preliminary and final form as well as any supplements thereto); (v) all fees and expenses incurred in connection with any “road show” for underwritten offerings, including all costs of travel (commercial
coach class only), lodging and meals; (vi) all transfer agent’s and registrar’s fees; (vii) all fees and expenses of counsel to the Company; (viii) all fees and expenses of the Company’s independent public accountants
(including any fees and 

  
 -13- 

 
expenses arising from any special audits or “comfort letters”) and any other Persons retained by the Company in connection with or incident to any registration of Registrable Securities
pursuant to this Agreement; and (ix) all fees and expenses of underwriters (other than Selling Expenses) customarily paid by the issuers or sellers of securities (all such costs, fees and expenses, “Registration Expenses”).
Each Investor shall pay the fees and expenses of any counsel engaged by such Investor and shall bear its respective Selling Expenses associated with a registered sale of its Registrable Securities pursuant to this Agreement. 

(b)    The obligation of the Company to bear and pay the Registration Expenses shall apply irrespective of whether a
registration, once properly demanded or requested, becomes effective or is withdrawn or suspended; provided, that the Registration Expenses for any Registration Statement withdrawn solely at the request of one or more Investor(s) (unless
withdrawn following commencement of a suspension pursuant to Section 1.4(c)) shall be borne by such Investor(s). 

1.9    Indemnification. 

(a)    In connection with the registration of Registrable Securities pursuant to this Agreement, the Company agrees to
indemnify and hold harmless, and hereby does indemnify and hold harmless, the Parent and the other Investors, their affiliates and their respective directors, officers, employees and partners and each Person who is a “controlling person”
of the Parent or the other Investors (within the meaning of the Securities Act or the Exchange Act) against, and pay and reimburse the Parent and the other Investors, affiliate, director, officer, employee or partner or controlling person for
any losses, claims, damages and liabilities (collectively, “Losses”), joint or several, to which the Parent and the other Investors or any such affiliate, director, officer, employee or partner or controlling person may become
subject under the Securities Act or otherwise, insofar as such Losses (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon (i) any untrue or alleged untrue statement of material
fact contained in any Registration Statement, prospectus or preliminary prospectus or any amendment thereof or supplement thereto, or any “issuer free writing prospectus” as such term is defined under Rule 433 under the Securities Act or
(ii) any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, and the Company will pay and reimburse the Parent and the other Investors and each such
affiliate, director, officer, employee, partner and controlling person for any legal or any other expenses actually and reasonably incurred by them in connection with investigating, defending or settling any such loss, claim, liability, action or
proceeding; provided that the Company will not be liable in any such case to the extent that any such Losses arise out of or are based upon an untrue statement or alleged untrue statement, or omission or alleged omission, made in such
Registration Statement, any such prospectus or preliminary prospectus or any amendment or supplement thereto, or any “issuer free writing prospectus” as such term is defined under Rule 433 under the Securities Act, or in any application,
in reliance upon, and in conformity with, written information prepared and furnished to the Company by the Parent, any other Investor or any such affiliate, director, officer, employee, partner and controlling person expressly for use therein and
provided, further, that the Company shall not be liable to the extent that any Losses arise out of or are based upon the use of any prospectus after such time as the Company has advised Parent or any other Investor in writing that a
post-effective amendment or supplement thereto is required. 

  
 -14- 

 (b)    In connection with any Registration Statement in which the Parent
or any other Investor is participating, the Parent and each other Investor will furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or
prospectus and will indemnify and hold harmless the Company, its directors and officers, each underwriter and each other Person who is a “controlling person” of the Company (within the meaning of the Securities Act or the Exchange
Act) against any Losses, joint or several, to which the Company or any such director or officer, any such underwriter or controlling person may become subject under the Securities Act or otherwise, insofar as such Losses (or actions or
proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon (i) any untrue or alleged untrue statement of material fact contained in the Registration Statement, prospectus or preliminary prospectus or
any amendment thereof or supplement thereto or in any application, (ii) any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) the failure of
such Investor to deliver a prospectus in accordance with the requirements of the Securities Act, but, with respect to clauses (i) and (ii), only to the extent that such untrue statement or omission is made in such Registration Statement, any
such prospectus or preliminary prospectus or any amendment or supplement thereto, or in any application, in each case in reliance upon, and in conformity with, written information prepared and furnished to the Company by the Parent or any other
Investor expressly for use therein, and the Parent and any such other Investor will reimburse the Company and each such director, officer, underwriter and controlling Person for any legal or any other expenses actually and reasonably incurred by
them in connection with investigating, defending or settling any such loss, claim, liability, action or proceeding; provided that the obligation to indemnify and hold harmless will be limited to the net amount of proceeds received by the
Parent and each other Investor (in the aggregate) from the sale of Registrable Securities pursuant to such Registration Statement. 

(c)    Any Person entitled to indemnification hereunder will (i) give prompt written notice to the indemnifying party
of any claim with respect to which it seeks indemnification and (ii) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim,
permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party (such consent not to be unreasonably withheld). If such defense is assumed, the indemnifying party will not be subject
to any liability for any settlement made by the indemnified party without its consent (but such consent will not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim will not be
obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, provided that the indemnifying party will be liable for one additional counsel if in the
reasonable judgment of counsel for any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. 

(d)    The indemnification provided for under this Agreement will remain in full force and effect regardless of any
investigation made by or on behalf of the indemnified party or any officer, director or controlling Person of such indemnified party and will survive the registration and sale of any securities by any Person entitled to any indemnification hereunder
and the expiration or termination of this Agreement. 

  
 -15- 

 (e)    If the indemnification provided for in this
Section 1.9 is legally unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party
thereunder, will contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one
hand and of the indemnified party on the other hand in connection with the statements or omissions which resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable considerations. The relative fault of the
indemnifying party and the indemnified party will be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. Notwithstanding the foregoing, the amount the Parent and any
other Investor will be obligated to contribute pursuant to this Section 1.9(e) will be limited to an amount equal to the proceeds received by the Parent and each other Investor (in the aggregate) in respect of the
Registrable Securities sold pursuant to the Registration Statement which gives rise to such obligation to contribute (less the aggregate amount of any damages which the Parent and each other Investor has otherwise been required to pay in respect of
such loss, claim, damage, liability or action or any substantially similar loss, claim, damage, liability or action arising from the sale of such Registrable Securities). 

1.10    Participation in Underwritten Registrations. No Person may participate in
any underwritten offering pursuant to this Agreement unless such Person (i) agrees to sell such Person’s securities on the basis provided in any underwriting arrangements in customary form approved by the Persons entitled under this
Agreement to approve such arrangements and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements;
provided, that no Investor included in any underwritten offering shall be required to make any representations or warranties to the Company or the underwriters (other than representations and warranties regarding (A) such Investor’s
ownership of its Registrable Securities to be sold in such offering, (B) such Investor’s power and authority to effect such Transfer and (C) such matters pertaining to such Investor’s compliance with securities laws as may be
reasonably requested by the managing underwriter(s)) or to undertake any indemnification obligations to the Company or the underwriters with respect thereto, except to the extent otherwise provided in Section 1.9 hereof.

 1.11    Rule 144 and 144A Reporting. 

(a)    With a view to making available the benefits provided by Rule 144 which may permit the sale of the Registrable
Securities to the public without registration, the Company agrees to use its commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act and keep public information available at any time when the Company is subject to such reporting requirements. 
 Upon request of the
Parent or the other Investors, the Company will deliver to the Parent and the other Investors a written statement as to whether it has complied with such informational 

  
 -16- 

 
and reporting requirements and will, within the limitations of the exemptions provided by Rule 144 (as such rule may be amended from time to time) or any similar rule enacted by the
SEC, instruct the transfer agent to remove the restrictive legend affixed to any Registrable Securities to enable such shares to be sold in compliance with Rule 144 (as such rule may be amended from time to time) or any similar rule
enacted by the SEC. 
 (b)    For purposes of facilitating sales pursuant to Rule 144A, so long as the Company is not
subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Parent, each Investor and any prospective purchaser of the Parent’s or any Investor’s securities will have the right to obtain from the
Company, upon written request of the Parent prior to the time of sale, a copy of the most recent annual or quarterly report of the Company, and such other reports and documents that the Company would have been required to file if the Company were
subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act as the Parent, the Investors or prospective purchaser may reasonably request in writing in availing itself of any rule or regulation of the SEC allowing the
Parent or any other Investor, as applicable, to sell any such securities without registration. 

1.12    Miscellaneous. 

(a)    No Inconsistent Agreements. The Company represents and warrants that it has not entered into, and agrees
that it will not enter into, any agreement with respect to its securities that violates or subordinates or is otherwise inconsistent with the rights granted to the Investors under this Agreement. 

(b)    Adjustments Affecting Registrable Securities. The Company will not on its own initiative, except to the
extent required by applicable law or an enforceable court order, propose any of the following actions to be taken by the general meeting of shareholders after the date of this Agreement with respect to Registrable Securities if such actions would
materially and adversely affect the ability of the Parent or the other Investors to include the Registrable Securities in a registration undertaken pursuant to this Agreement: (i) implementing Transfer restrictions on Registrable Securities,
(ii) implementing limits on dispositions of Registrable Securities, (iii) adopting restrictions on the nature of Transferees of Registrable Securities or (iv) implementing or adopting any similar restrictions or limitations with
respect to the Transfer of Registrable Securities in violation of the terms of this Agreement. For the avoidance of doubt, any actions which occur by operation of Law, pursuant to an enforceable court order or are taken by the general meeting of
shareholders shall not be deemed to be a violation of this Section 1.12(b). 
 (c)    DTC
Eligibility. The Company shall use its commercially reasonable efforts to cause the Registrable Securities, concurrently with the registration of such Registrable Securities pursuant to this ARTICLE I, to be eligible for the depository
and book-entry transfer services of The Depository Trust Company. 
 1.13    Subject
to Transfer Restrictions. For the avoidance of doubt, any exercise by any Investor of its rights pursuant to Section 1.1 or Section 1.2 shall at all times be subject to the limitations set
forth in Section 2.1. 

  
 -17- 

 ARTICLE II 

COVENANTS 
 
2.1    Transfer Restrictions. 
 (a)    Other than Permitted Transfers, neither the
Parent nor any Investor shall Transfer any Company Common Shares until the date that is the twelve (12) month anniversary of the Closing Date (such date, the “Restricted Period Termination Date”). 

(b)    “Permitted Transfer” means, in each case so long as such Transfer is in accordance with applicable
Law: 
 (i)    a Transfer of Company Common Shares to a Permitted Transferee, so long as such Permitted
Transferee, to the extent it has not already done so, executes a customary joinder to this Agreement, in form and substance reasonably acceptable to the Company, in which such Permitted Transferee agrees to be an “Investor” for all
purposes of this Agreement; 
 (ii)    a Transfer of Company Common Shares in connection with a Merger
Transaction approved by the Board; and 
 (iii)    a Transfer of Company Common Shares to the Company.

 (c)    Notwithstanding anything to the contrary contained herein, including the occurrence of the Restricted Period
Termination Date, none of the Parent or any other Investor shall Transfer any Company Common Shares other than in accordance with all applicable Laws and the other terms and conditions of this Agreement. 

(d)    In connection with any Transfer to a Permitted Transferee prior to the termination of this Agreement pursuant to
Section 4.1, the Parent shall cause any Permitted Transferee to execute a customary joinder to this Agreement, in form and substance reasonably acceptable to the Company, in which such Permitted Transferee agrees to become
a party to this Agreement and to be an “Investor” for all purposes of this Agreement and provides notice information for the purposes of Section 4.2. 

2.2    Standstill. 

(a)    For so long as the Parent and the other Investors Beneficially Own Company Common Shares representing at least
thirty-three percent (33%) of the Company Common Shares issued to the Parent pursuant to the Stock Purchase Agreement, without the prior written consent of the Company, the Parent shall not, and shall cause each of the other Investors not to,
directly or indirectly: 
 (i)    acquire, offer to acquire or agree to acquire Beneficial Ownership of
Company Common Shares, except pursuant to share splits, reverse share splits, share dividends or distributions, or combinations or any similar recapitalizations on or after the date hereof; 

  
 -18- 

 (ii)    effect or seek, offer or propose (whether
publicly or otherwise) to effect, or announce any intention to effect or cause or participate in or in any way assist or encourage any other Person to effect or seek, offer or propose (whether publicly or otherwise) to effect or participate in
(a) any acquisition of any securities (or beneficial ownership thereof) or assets of the Company or any of its Affiliates, including rights or options to acquire such ownership; (b) initiate or propose any merger, tender offer, business
combination, restructuring, recapitalization or other extraordinary transaction involving, or any change of control of, the Company or any of its Subsidiaries; or (c) any shareholder proposal or make, or in any way participate in, directly or
indirectly, any “solicitation” of “proxies” to vote, or seek to influence any Person with respect to the voting of, Company Common Shares, or become a “participant” in a “solicitation” (as such terms are
defined in Regulation 14A under the Exchange Act) with respect to Company Common Shares; 

(iii)    deposit any Company Common Shares into a voting trust or subject Company Common Shares to any
proxy, arrangement or agreement with respect to the voting of such securities or other agreement having a similar effect; 

(iv)    initiate or propose a call for any special meeting of the Company’s shareholders; 

(v)    seek or propose to influence, advise, change or control the management, board of directors of the
Company, governing instruments or policies of the Company or any of its Subsidiaries; 

(vi)    participate in any acquisition of assets or business of the Company or its Subsidiaries or
Affiliates outside of the ordinary course of business; or 
 (vii)    propose, or agree to, or enter
into any discussions, negotiations or arrangements with, or provide any confidential information to, any third party with respect to any of the foregoing. 

(b)    The prohibition in Section 2.2(a)(i) shall not apply to ordinary course of business
activities of the Parent, each Investor or any of their respective Affiliates in connection with: 

(i)    proprietary and third party fund and asset management activities; 

(ii)    brokerage and securities trading activities; 

(iii)    financial services and insurance activities; 

(iv)    acquisitions made as a result of (A) a share split, share dividend, reorganization,
recapitalization, reclassification, combination, exchange of shares or other like change or (B) in connection with securing or collecting indebtedness previously contracted in good faith and not with the intention of circumventing the
prohibition in Section 2.2(a)(i); and 

  
 -19- 

 (v)    acquisitions made in connection with a
transaction in which the Parent, any of the Investors or any of their respective Affiliates acquires a previously unaffiliated business entity that Beneficially Owns Company Common Shares, or any securities convertible into, or exercisable or
exchangeable for, Company Common Shares, at the time of the consummation of such acquisition; 
 provided that, in the case of each of
(i) through (v) of this Section 2.2(b), such ordinary course of business activities shall be made without the intent to influence the control of the Company. 

2.3    Ownership Threshold. Neither any Investor nor the Company shall take any
action that could reasonably be expected to result in the Parent, the Investors or any of their respective Affiliates, acting alone or as part of a Group, directly or indirectly, either to Beneficially Own nine and nine-tenths percent
(9.9%) or more of the Company Common Shares, or any securities convertible into, or exercisable or exchangeable for, Company Common Shares; provided that if the Parent, the Investors or any of their respective Affiliates
(collectively) do come to Beneficially Own nine and nine-tenths percent (9.9%) or more of the Company Common Shares, or any securities convertible into, or exercisable or exchangeable for, Company Common Shares or (the number of securities
in excess of such nine and nine-tenths percent (9.9%) levels, the “Excess Shares Amount”), (a) the Parent and each other Investor may Transfer a number of such Equity Securities equal to the Excess Shares Amount multiplied
by its Pro Rata Portion freely without regard to the Transfer restrictions set forth in Section 2.1, so long as the Transferee of such Equity Securities, if it is not a Permitted Transferee that has already executed a
joinder as provided in Section 2.1(d), executes a written instrument, in form and substance reasonably acceptable to the Company, in which such Transferee agrees not to Transfer such Equity Securities until the Restricted
Period Termination Date, and (b) in the event of an action taken by the Company that causes such ownership thresholds to be exceeded (other than share repurchases conducted by the Company in the ordinary course of business consistent with past
practice), the Company and the Investors shall negotiate in good faith for the Company to repurchase Equity Securities from the Investors so that the Investors (collectively) will no longer Beneficially Own nine and nine-tenths percent
(9.9%) or more of the Company Common Shares, or any securities convertible into, or exercisable or exchangeable for, Company Common Shares (excluding securities that are not convertible in the hands of the holder). 

2.4    Listing. The Company agrees to use commercially reasonable efforts to cause
the Company Common Shares to continue to be listed on the New York Stock Exchange or another national securities exchange. 
 
2.5    Private Sale and Legends. 
 (a)    Except as provided in
Section 2.1, the Company agrees that nothing in this Agreement shall prohibit the Investors, at any time and from time to time, from selling or otherwise Transferring Company Common Shares pursuant to a private sale or
other transaction which is not registered pursuant to the Securities Act. 
 (b)    At the request of an Investor and to
the extent the Company Common Shares are subject to a restrictive legend, whether such securities are certificated or held in book-entry form, (i) the purchaser who takes ownership from an Investor holding any certificates

  
 -20- 

 
for such Company Common Shares shall be entitled to receive from the Company new certificates for the appropriate number of Company Common Shares not bearing such legend (or the elimination or
termination of such comparable notations or arrangements on securities held in book-entry form) and (ii) the Company shall use its commercially reasonable efforts to procure the cooperation of the Company’s transfer agent in removing such
legend (or the elimination or termination of such notations or arrangements). If required by the Company or the Company’s transfer agent, the Investor shall deliver an opinion of its counsel that the restriction referenced in such legend (or
such notations or arrangements) is no longer required in order to ensure compliance with the Securities Act. 

ARTICLE III 

[INTENTIONALLY OMITTED] 
 ARTICLE
IV 
 MISCELLANEOUS 

4.1    Term. This Agreement will be effective as of the Closing Date and shall
automatically terminate at such time as the Investors no longer Beneficially Own any Registrable Securities or, if earlier, the third anniversary of the effective date of the Shelf Registration Statement filed pursuant to
Section 1.1(a). If this Agreement is terminated pursuant to this Section 4.1, this Agreement shall become void and of no further force and effect, except for the provisions set forth in this
ARTICLE IV and any confidentiality obligations pursuant to Sections 1.7(a)(v) and 1.7(a)(ix). 
 
4.2    Notices. 
 (a)    All notices, requests, claims, demands and other communications
under this Agreement shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service, by email with receipt confirmed (followed by delivery of an
original via overnight courier service) or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties hereto at the following respective addresses (or at such other address for a party hereto as shall be
specified in a notice given in accordance with this Section 4.2): 
  

	 	(i)	 if to the Parent: 

Tokio Marine & Nichido Fire Insurance Co., Ltd. 

2-1, Marunouchi 1-Chome,
Chiyoda-ku 
 Tokyo 100-0005 Japan 

Attention: Commercial Lines Marketing Department 

Email: s.naganuma@tokiomarinehd.com 

  
 -21- 

 with a copy to (which shall not constitute notice): 

Sullivan & Cromwell LLP 

125 Broad Street 
 New York, NY
10004-2498 

	 	Attention:	 Robert G. DeLaMater 

	 	Email:	 delamaterr@sullcrom.com 

 

	 	(ii)	 if to the Company: 

RenaissanceRe Holdings Ltd. 

Renaissance House 
 12 Crow Lane

 Pembroke HM 19, Bermuda 

	 	Attention:	 General Counsel 

	 	Email:	 shw@renre.com 

with a copy to (which shall not constitute notice): 

Willkie Farr & Gallagher LLP 

787 Seventh Avenue 
 New York,
NY 10019 

	 	Attention:	 Steven J. Gartner 

	 	    	 Sean M. Ewen 

	 	Email:	 sgartner@willkie.com 

	 	    	 sewen@willkie.com 

4.3    Investor Actions. Any determination, consent or approval of, or notice or
request delivered by, or any similar action of, the Investors (each, an “Investor Action”) shall be made by, and shall be valid and binding upon, all Investors if made by (i) holders of a majority of the Registrable
Securities then Beneficially Owned by all Investors or (ii) the Parent; provided, that in the event of any conflict between any Investor Action made by holders of a majority of the Registrable Securities then Beneficially Owned by all
Investors and an Investor Action made by the Parent, the Investor Action made by the Parent shall control. 

4.4    No Partnership. Nothing in this Agreement shall be taken to constitute a
partnership between any of the parties to this Agreement or the appointment of the parties to this Agreement as agent for the others. 
 
4.5    Memorandum of Association. Upon the occurrence of a conflict between any provision of this Agreement and any provision of the Memorandum of Association, then this Agreement will prevail, subject to applicable
Law, and in the event applicable Law would conflict with the provisions of this Agreement, the Company will use its commercially reasonable efforts to facilitate the provision of this Agreement. 

4.6    Amendments and Waivers. No provision of this Agreement may be amended,
supplemented or modified except by a written instrument signed by all of the parties thereto. No provision of this Agreement may be waived except by a written instrument signed by the party 

  
 -22- 

 
against whom the waiver is to be effective. No failure or delay by any party hereto in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or
partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by Law.

 4.7    Assignment of Registration Rights. The rights of the Parent and any
other Investor to registration of all or any portion of its Registrable Securities pursuant to this Agreement may be assigned by the Parent or such Investor to any Permitted Transferee to the extent of the Registrable Securities Transferred as long
as (i) the Parent or such Investor, within ten (10) days after such Transfer, furnishes to the Company written notice of the Transfer to the Permitted Transferee and (ii) such Permitted Transferee agrees, following such Transfer, to
be subject to all applicable restrictions and obligations set forth in this Agreement, and executes a customary joinder to this Agreement, in form and substance reasonably acceptable to the Company, in which case the applicable Permitted Transferee
shall be the beneficiary to all rights of the Parent or such Investor and subject to all restrictions and obligations applicable to the Parent or such Investor pursuant to this Agreement, to the same extent as the Parent or such Investor. 

4.8    Assignment. Except as provided in Section 4.7
hereof, this Agreement shall not be assigned, in whole or in part, by operation of law or otherwise without the prior written consent of the parties hereto. Any attempted assignment in violation of this Section 4.8 shall be
void. This Agreement shall be binding upon, shall inure to the benefit of, and shall be enforceable by the parties hereto and their successors and permitted assigns. 

4.9    Severability. If any term or other provision of this Agreement is invalid,
illegal or incapable of being enforced under any Law or as a matter of public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the
transactions contemplated by this Agreement is not affected in any manner materially adverse to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall
negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated as
originally contemplated to the greatest extent possible. 

4.10    Counterparts. This Agreement may be executed in one or more counterparts,
and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a
signature page to this Agreement by facsimile or other means of electronic transmission shall be as effective as delivery of a manually executed counterpart of this Agreement. 

4.11    Entire Agreement. Except as otherwise expressly provided in this
Agreement, this Agreement constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and undertakings, both written and oral, between or on behalf of the Parent and/or its
Affiliates, on the one hand, and the Company and/or its Affiliates, on the other hand, with respect to the subject matter hereof. 

  
 -23- 

 4.12    Governing Law; Jurisdiction;
Waiver of Jury Trial; Agent for Service of Process. Section 11.10 of the Stock Purchase Agreement shall apply to this Agreement mutatis mutandis.  

4.13    Specific Performance. (a) The parties hereto agree that irreparable
damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, (b) it is accordingly agreed that, without the necessity of posting bond or
other undertaking, the parties hereto shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Agreement, this being in
addition to any other remedy to which such party is entitled at law or in equity and (c) in the event that any Action is brought in equity to enforce the provisions of this Agreement, no party hereto shall allege that, and each party hereto
hereby waives the defense or counterclaim that, there is an adequate remedy at law. 

4.14    No Third Party Beneficiaries. This Agreement is for the sole benefit of
the parties hereto and their successors and permitted assigns, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever under or
by reason of this Agreement. 
 4.15    Defined Terms. Capitalized terms when
used in this Agreement have the following meanings: 
 “Action” means any claim, action, suit, arbitration or proceeding by
or before any Governmental Authority, court, tribunal or arbitration body. 
 “Affiliate” means, with respect to any
Person, any other Person that, at the time of determination, directly or indirectly through one or more intermediaries, Controls, is Controlled by or is under common Control with such Person; provided that for the avoidance of doubt, the
Company and the Parent shall not be deemed to be Affiliates of each other. 
 “Agreement” has the meaning set forth in the
preamble. 
 “Automatic Shelf Registration Statement” means an “automatic shelf registration statement” as
defined in Rule 405 under the Securities Act. 
 “Beneficial Owner,” “Beneficially Own” or
“Beneficial Ownership” has the meaning assigned to such term in Rule 13d-3 under the Exchange Act, and a Person’s Beneficial Ownership of securities shall be calculated in accordance with
the provisions of such Rule (in each case, irrespective of whether or not such Rule is actually applicable in such circumstance). In addition, a Person shall be deemed to be the Beneficial Owner of, and shall be deemed to Beneficially Own, and shall
be deemed to have Beneficial Ownership of, any securities which are the subject of, or the reference securities for, or that underlie, any Derivative Instrument of such Person, with the number of securities Beneficially Owned being the notional or
other number of securities specified in the documentation evidencing the Derivative Instrument as being subject to be acquired upon the exercise or settlement of the Derivative Instrument or as the basis upon which the value or settlement amount of
such Derivative Instrument is to be calculated in whole or in part or, if no such number of securities is specified in such documentation, as determined by the Board in its sole discretion to be the number of securities to which the Derivative
Instrument relates. 

  
 -24- 

 “Board” means the Board of Directors of the Company. 

“Business Day” means any day that is not a Saturday, a Sunday or other day on which commercial banks in the City of New York,
New York or Tokyo, Japan are required or authorized by Law to remain closed. 
 “Closing Date” shall have the meaning
ascribed to it in the Stock Purchase Agreement. 
 “Company” has the meaning set forth in the preamble and includes the
Company’s successors by merger, acquisition, reorganization or otherwise. 
 “Company Common Shares” means the common
shares, par value $1.00 per share, of the Company. 
 “Contract” means any contract, agreement, instrument, undertaking,
indenture, commitment, loan, license, settlement, consent, note or other legally binding obligation (whether or not in writing). 

“Control,” “Controlled” and “Controlling” means, with respect to any Person, the power to
direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise, and the terms “Controlled by” and “under common Control with” shall be
construed accordingly. 
 “Controlled Affiliate” means any Affiliate of the specified Person that is, directly or
indirectly, Controlled by the specified Person. 
 “Demand Registration” has the meaning set forth in
Section 1.2(a). 
 “Demand Registration Request” has the meaning set forth in
Section 1.2(a). 
 “Derivative Instruments” means any and all derivative securities (as defined
under Rule 16a-1 under the Exchange Act) that increase in value as the value of any Equity Securities of the Company increases, including a long convertible security, a long call option and a short
put option position, in each case, regardless of whether (i) such derivative security conveys any voting rights in any Equity Security, (ii) such derivative security is required to be, or is capable of being, settled through delivery of
any Equity Security or (iii) other transactions that hedge the value of such derivative security. 
 “Encumbrance”
means any mortgage, commitment, transfer restriction, deed of trust, pledge, option, power of sale, retention of title, right of pre-emption, right of first refusal, executorial attachment, hypothecation,
security interest, encumbrance, claim, lien or charge of any kind, or an agreement, arrangement or obligation to create any of the foregoing. 

“Equity Securities” means any and all (i) shares, interests, participations or other equivalents (however
designated) of capital stock or other voting securities of a corporation, any 

  
 -25- 

 
and all equivalent or analogous ownership (or profit) or voting interests in a Person (other than a corporation), (ii) securities convertible into or exchangeable for shares, interests,
participations or other equivalents (however designated) of capital stock or voting securities of a corporation, and securities convertible into or exchangeable for any equivalent or analogous ownership (or profit) or voting interests in a
Person (other than a corporation), and (iii) any and all warrants, rights or options to purchase any of the foregoing, whether voting or nonvoting, and, in each case, whether or not such shares, interests, participations, equivalents,
securities, warrants, options, rights or other interests are authorized or otherwise existing on any date of determination; provided that Equity Securities shall not include preference shares (or depositary shares representing interests in
preference shares) that are not convertible or exchangeable for common shares in a corporation. 
 “Excess Shares Amount”
has the meaning set forth in Section 2.3. 
 “Exchange Act” means the Securities Exchange Act of
1934, as amended, or any similar federal statute and the rules and regulations thereunder, as in effect from time to time. 

“FINRA” means the Financial Industry Regulatory Authority, Inc. 

“GAAP” means generally accepted accounting principles in the United States of America. 

“Governmental Authority” means any supranational, national, regional, federal, state, provincial, territorial, municipal or
local court, administrative body or other governmental or quasi-governmental entity or authority or SRO with competent jurisdiction (including any arbitration panel or body) exercising legislative, judicial, regulatory or administrative
functions of or pertaining to supranational, national, regional, federal, state, provincial, territorial, municipal or local government, including any department, commission, board, agency, bureau, subdivision, instrumentality or other regulatory,
administrative, arbitral or judicial authority. 
 “Group” has the meaning assigned to such term in
Section 13(d)(3) of the Exchange Act. 
 “Interruption Period” has the meaning set forth in
Section 1.7(d). 
 “Investor” means each of the Parent, any successor and any Permitted
Transferee who becomes a party hereto pursuant to Section 4.7. 
 “Investor Action” has the
meaning set forth in Section 4.3. 
 “Law” means any supranational, federal, state, local or
foreign law (including common law), statute or ordinance, or any rule, regulation, or agency requirement of any Governmental Authority. 

“Losses” has the meaning set forth in Section 1.9(a). 

“Memorandum of Association” means the Company’s memorandum of association as then in effect. 

  
 -26- 

 “Merger Transaction” means any transaction or series of related
transactions involving: (i) any acquisition (whether direct or indirect, including by way of merger, share exchange, consolidation, business combination or other similar transaction) or purchase from the Company or any of its Subsidiaries
that would result in any Person or Group Beneficially Owning more than fifty percent (50%) of the total outstanding Equity Securities of the Company (measured by voting power or economic interest), (ii) any tender offer, exchange offer or other
secondary acquisition that would result in any Person or Group Beneficially Owning more than fifty percent (50%) of the total outstanding Equity Securities of the Company (measured by voting power or economic interest), or (iii) any transaction
pursuant to which Company Common Shares are exchanged for, or canceled and converted into the right to receive, another security. 

“Non-Underwritten Shelf Take-Down” has the meaning set forth in
Section 1.1(g). 
 “Non-Underwritten Shelf Take-Down
Notice” has the meaning set forth in Section 1.1(g). 
 “Other Stockholders” shall mean
Persons who by virtue of agreements with the Company (other than this Agreement) are entitled to include their securities in any registration of the offer or sale of securities pursuant to the Securities Act. 

“Parent” has the meaning set forth in the preamble. 

“Permitted Transfer” has the meaning set forth in Section 2.1(b). 

“Permitted Transferees” means (i) the Parent and (ii) any Controlled Affiliate who holds at least one hundred
thousand (100,000) Registrable Securities following the Transfer. 
 “Person” means an individual, a partnership, a joint
venture, a corporation, a limited liability company, a trust, an unincorporated organization or a government or department or agency thereof. 

“Piggyback Registration” has the meaning set forth in Section 1.5(a). 

“Piggyback Shelf Registration Statement” has the meaning set forth in Section 1.5(a). 

“Piggyback Shelf Take-Down” has the meaning set forth in Section 1.5(a). 

“Pro Rata Portion” means, with respect to any Investor, the ratio determined by dividing (A) the number of shares of
Equity Securities held by such Investor (including through any securities convertible into, or exercisable or exchangeable for, Equity Securities) by (B) the total number of shares of Equity Securities held by all Investors in the aggregate
(including through any securities convertible into, or exercisable or exchangeable for, Equity Securities). 
 “Register,”
“registered” and “registration” (regardless of case) refer to a registration effected by preparing and filing a Registration Statement in compliance with the Securities Act, and the declaration or ordering of the
effectiveness of such Registration Statement, and compliance with applicable state securities laws of such states in which the Parent notifies the Company of its or any Investor’s intention to offer Registrable Securities. 

  
 -27- 

 “Registrable Securities” means (i) any Company Common Shares issued
pursuant to the Stock Purchase Agreement or (ii) any Equity Securities, including Company Common Shares, issued or issuable directly or indirectly with respect to the Company Common Shares issued pursuant to the Stock Purchase Agreement by way
of conversion or exchange thereof or share dividend or share split or in connection with a combination of shares, recapitalization, reclassification, merger, amalgamation, arrangement, consolidation or other reorganization. As to any particular
securities constituting Registrable Securities, such securities will cease to be Registrable Securities when (x) they have been effectively registered or qualified for sale by prospectus filed under the Securities Act and disposed of in
accordance with the Registration Statement covering such securities or (y) they have been sold to the public through a broker, dealer or market maker pursuant to Rule 144 or other exemption from registration under the Securities Act. For
purposes of this Agreement, a Person will be deemed to be a holder of Registrable Securities whenever such Person has the right to acquire directly or indirectly such Registrable Securities (upon conversion or exercise in connection with a transfer
of securities or otherwise, but disregarding any restrictions or limitations upon the exercise of such right), whether or not such acquisition has actually been effected. 

“Registration Expenses” has the meaning set forth in Section 1.8(a). 

“Registration Statement” means the prospectus and other documents filed with the SEC to effect a registration under the
Securities Act. 
 “RenRe Share Amount” has the meaning ascribed to it in the Stock Purchase Agreement. 

“Restricted Period Termination Date” has the meaning set forth in Section 2.1(a). 

“Rule 144” means Rule 144 under the Securities Act or any successor or similar rule as may be enacted by the SEC from time to
time, as in effect from time to time. 
 “Rule 144A” means Rule 144A under the Securities Act or any successor or similar
rule as may be enacted by the SEC from time to time, as in effect from time to time. 
 “SEC” means the United States
Securities and Exchange Commission or any other federal agency administering the Securities Act. 
 “Securities Act” means
the United States Securities Act of 1933, as amended, or any similar federal statute and the rules and regulations thereunder, as in effect from time to time. 

“Selling Expenses” means all underwriting discounts, selling commissions and transfer taxes applicable to the sale of
Registrable Securities hereunder. 
 “Shelf Registration” means registering under the Securities Act an offering of
securities to be made on a delayed or continuous basis pursuant to Securities Act Rule 415 or any successor rule thereto on a Shelf Registration Statement (or an existing Automatic Shelf Registration Statement or a prospectus supplement that shall
be deemed to be part of an existing Automatic Shelf Registration Statement in accordance with Rule 430B under the Securities Act). 

  
 -28- 

 “Shelf Registration Statement” means a Registration Statement on Form S-3 or the then-appropriate form for an offering to be made on a delayed or continuous basis pursuant to Rule 415 under the Securities Act or any successor rule thereto. 

“Shelf Take-Down” has the meaning set forth in Section 1.1(d). 

“Signing Date” has the meaning set forth in the recitals. 

“SRO” means (i) any “self-regulatory organization” as defined in Section 3(a)(26) of the Exchange
Act, (ii) any other United States or foreign securities exchange, futures exchange, commodities exchange or contract market or (iii) any other securities exchange. 

“Stock Purchase Agreement” has the meaning set forth in the recitals. 

“Subsidiary” in respect of a Person, means any corporation, partnership, joint venture, trust, limited liability company,
unincorporated association or other entity in respect of which such Person: (w) is entitled to more than 50% of the interest in the capital or profits; (x) holds or controls a majority of the voting securities or other voting interests;
(y) has rights via holdings of debt or other contract rights that are sufficient for control and consolidation for GAAP or IFRS purposes, as applicable; or (z) has the right to appoint or elect a majority of the board of directors or
Persons performing similar functions. 
 “Transfer” means (i) any direct or indirect sale, lease, assignment,
Encumbrance, disposition or other transfer (by operation of law or otherwise), either voluntary or involuntary, or entry into any Contract, option or other arrangement or understanding with respect to any sale, lease, assignment, Encumbrance,
disposition or other transfer (by operation of law or otherwise), of any Equity Security or (ii) to enter into any Derivative Instrument, swap or any other Contract, agreement, transaction or series of transactions that hedges or transfers, in
whole or in part, directly or indirectly, the economic consequence of ownership of any Equity Security, whether any such Derivative Instrument, swap, Contract, agreement, transaction or series of transactions is to be settled by delivery of
securities, in cash or otherwise. 
 “Transferee” means a Person to whom a Transfer is made or is proposed to be made. 

“Underwritten Shelf Take-Down” has the meaning set forth in Section 1.1(e). 

“Underwritten Shelf Take-Down Notice” has the meaning set forth in Section 1.1(e). 

4.16    Interpretation. The words “hereof” and “herein” and
similar words shall be construed as references to this Agreement as a whole and not limited to the particular Article or Section in which the reference appears. Unless the context otherwise requires, references herein: (x) to Articles or
Sections mean the Articles or Sections of this Agreement; and (y) to an agreement, instrument or other document, means such agreement, instrument or other document as amended, supplemented and modified from time to time to the extent permitted
by the provisions thereof. Any reference to a wholly owned Subsidiary of a Person shall mean such Subsidiary is directly or indirectly wholly owned by such Person. The meanings of defined terms are equally applicable to the singular and plural forms
of the defined terms. No rule of construction against the draftsperson shall be applied in connection with the interpretation or 

  
 -29- 

 
enforcement of this Agreement and this Agreement shall be interpreted literally not taking into account any other facts or circumstances, including any conduct, actions, statements, intentions,
assumptions or beliefs of any of the parties at any time, as this Agreement is the product of negotiations between sophisticated parties advised by counsel. The headings in this Agreement do not affect its interpretation. References to
“$”, “US$” or “U.S. dollars” are to U.S. dollars. Any reference to a “company” includes any company, corporation or other body corporate, wherever and however incorporated or established. Any reference to a
statute, statutory provision or subordinate legislation (“legislation”) includes references to: (a) that legislation as re-enacted or amended by or under any other legislation before or
after the Signing Date; (b) any legislation which that legislation re-enacts (with or without modification); and (c) any subordinate legislation made under that legislation before or after the
Signing Date, as re-enacted or amended as described in (a), or under any legislation referred to in (b). Any reference to writing shall include any mode of reproducing words in a legible and non-transitory form. References to one gender include all genders and references to the singular include the plural and vice versa. References to “ordinary course” or words of similar meaning when used in
this Agreement shall mean with respect to any Person “the ordinary course of business of such Person, consistent with past practice” unless specified otherwise. References to “includes” or “including” or words of
similar meaning when used in this Agreement shall mean “including without limitation” unless specified otherwise. 
 
4.17    Further Assurances. Each of the parties (as reasonably requested by the other party) shall execute and deliver, or shall cause to be executed and delivered, such documents and other instruments and shall take,
or shall cause to be taken, such further actions as may be reasonably required to carry out the provisions of this Agreement and give effect to the transactions contemplated by this Agreement. 

[The remainder of this page left intentionally blank.] 

  
 -30- 

 IN WITNESS WHEREOF, each of the parties has duly executed this Agreement as of the date and year set forth
above. 
 TOKIO MARINE & NICHIDO FIRE INSURANCE CO., LTD. 

			
		
	By:	 	/s/ Satoru Komiya
	Name:	 	Satoru Komiya
	Title:	 	Senior Managing Director

 Signature Page 

Registration Rights Agreement 

 IN WITNESS WHEREOF, each of the parties has duly executed this Agreement as of the date and year set forth
above. 
 RENAISSANCERE HOLDINGS LTD. 

			
		
	By:	 	/s/ Kevin J. O’Donnell
	Name:	 	Kevin J. O’Donnell
	Title:	 	Chief Executive Officer and President

 Signature Page 

Registration Rights Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}]]